Strain Name:


Stock Number:


Order this mouse


Repository- Live

Use Restrictions Apply, see Terms of Use
Common Names: IL-6-;    
These interleukin 6 (IL6) knock-out mutant mice show defects in responses to various viruses and in inflammatory responses to tissue damage or infection.


Strain Information

Former Names B6;129S6-Il6tm1Kopf    (Changed: 15-DEC-04 )
Type Targeted Mutation;
Additional information on Genetically Engineered and Mutant Mice.
Visit our online Nomenclature tutorial.
Mating SystemHomozygote x Homozygote         (Female x Male)   01-MAR-06
Specieslaboratory mouse
GenerationF?+40 (05-JAN-09)
Generation Definitions
Donating InvestigatorDr. Manfred Kopf,   ETH Zurich

Related Genotype: a/a

Mice homozygous for the targeted mutation are viable and fertile. No gene product (mRNA) is detected by RT-PCR analysis of lipopolysaccharide (LPS) challenged macrophages. Bioassay and enzyme-linked immunosorbent assay (ELISA) analysis of serum from LPS-challenged homozygotes reveals no detectable protein activity. These interleukin 6 (IL6) mutant mice show defects in responses to various viruses and in inflammatory responses to tissue damage or infection.

Of note, IL6-mutant mice may be available on different genetic backgrounds including mixed B6;129S2 (Stock No. 002254), C57BL/6J (Stock No. 002650), and BALB/cByJ (Stock No. 007078).

The interleukin 6 targeted mutation was created by Manfred Kopf and Georges Kohler (Max Planck Institut Fur Immunbiologie, Freiburg Germany). A targeting vector was designed to place a neomycin resistance cassette into the first coding exon (exon 2) of the targeted gene. This construct was electroporated into 129S2/SvPas-derived D3 embryonic stem (ES) cells. Heterozygotes were intercrossed to generate homozygotes.

Control Information

   101045 B6129SF2/J (approximate)
  Considerations for Choosing Controls

Related Strains

Strains carrying   Il6tm1Kopf allele
002650   B6.129S2-Il6tm1Kopf/J
021873   BXSB.129S2(B6)-Il6tm1Kopf/DcrJ
007078   CByJ.129S2(B6)-Il6tm1Kopf/J
View Strains carrying   Il6tm1Kopf     (3 strains)


Phenotype Information

View Related Disease (OMIM) Terms

Related Disease (OMIM) Terms provided by MGI
- Potential model based on gene homology relationships. Phenotypic similarity to the human disease has not been tested.
Arteriovenous Malformations of the Brain   (IL6)
Inflammatory Bowel Disease 1; IBD1   (IL6)
Kaposi Sarcoma, Susceptibility to   (IL6)
Rheumatoid Arthritis, Systemic Juvenile   (IL6)
View Mammalian Phenotype Terms

Mammalian Phenotype Terms provided by MGI
      assigned by genotype


        involves: 129S2/SvPas * C57BL/6
  • growth/size/body region phenotype
  • decreased body weight
    • lower body weight at 4 months of age is due largely to lower fat mass   (MGI Ref ID J:105633)
  • obese
    • obesity develops by 8 months of age   (MGI Ref ID J:105633)
  • immune system phenotype
  • abnormal T cell differentiation
    • thymocytes are consistently reduced by 20-40%   (MGI Ref ID J:17360)
  • abnormal acute phase protein level
    • 100-fold reduction in SAA production by the liver in response to turpentine injection or listeria infection   (MGI Ref ID J:17360)
  • abnormal microglial cell morphology
    • modest increase in microglial density after haloperidol treatment relative to the increase seen in controls   (MGI Ref ID J:79142)
  • decreased T cell number
    • T cells are reduced in the periphery by 20-40%   (MGI Ref ID J:17360)
  • decreased cytotoxic T cell cytolysis
    • cytolytic activity of CD8 T cells to vaccinia virus infected cells is reduced 3-10 fold   (MGI Ref ID J:17360)
  • increased susceptibility to bacterial infection
    • 10 to 100 fold increase in bacterial titers in the liver and spleen of mice infected with Listeria   (MGI Ref ID J:17360)
  • increased susceptibility to induced colitis
    • severe erosion of the intestinal epithelium from exposure to 3.5% dextran sodium sulfate   (MGI Ref ID J:79073)
  • increased susceptibility to viral infection
    • viral titers are 10-1000 fold higher in the ovaries and lungs of vaccinia virus infected mice   (MGI Ref ID J:17360)
  • hematopoietic system phenotype
  • abnormal T cell differentiation
    • thymocytes are consistently reduced by 20-40%   (MGI Ref ID J:17360)
  • abnormal microglial cell morphology
    • modest increase in microglial density after haloperidol treatment relative to the increase seen in controls   (MGI Ref ID J:79142)
  • decreased T cell number
    • T cells are reduced in the periphery by 20-40%   (MGI Ref ID J:17360)
  • decreased cytotoxic T cell cytolysis
    • cytolytic activity of CD8 T cells to vaccinia virus infected cells is reduced 3-10 fold   (MGI Ref ID J:17360)
  • cardiovascular system phenotype
  • abnormal capillary morphology
    • fewer capillaries in the heart   (MGI Ref ID J:150895)
  • abnormal cardiovascular system physiology
    • increased cell proliferation and apoptosis in 5 day old hearts   (MGI Ref ID J:150895)
    • proliferation at 5 days primarily by non myocytes   (MGI Ref ID J:150895)
    • apoptosis at 5 days primarily of myocytes   (MGI Ref ID J:150895)
    • decreased cardiac muscle contractility
      • both fractional shortening and ejection fraction are decreased in adults and at 5 and 15 days of age   (MGI Ref ID J:150895)
      • cardiac dysfunction beginning at 15 days of age   (MGI Ref ID J:150895)
      • cardiac dilation is more or less normal at 5 days of age   (MGI Ref ID J:150895)
  • abnormal heart morphology   (MGI Ref ID J:150895)
    • abnormal heart development
      • loss of cell-cell interaction between myocytes and fibroblasts   (MGI Ref ID J:150895)
      • increased number of fibroblasts and decreased numbers of myocytes   (MGI Ref ID J:150895)
    • abnormal heart ventricle morphology   (MGI Ref ID J:150895)
      • abnormal interventricular septum morphology
        • modestly increased interstitial collagen   (MGI Ref ID J:150895)
      • dilated heart left ventricle   (MGI Ref ID J:150895)
      • thin ventricular wall
        • both anterior and posterior walls of the left ventricle are thin   (MGI Ref ID J:150895)
        • increased interstitial collagen in the free walls of both left and right ventricles   (MGI Ref ID J:150895)
    • decreased heart weight
      • heart weight/body weight and heart weight/tibia length ratios both significantly reduced   (MGI Ref ID J:150895)
  • behavior/neurological phenotype
  • abnormal emotion/affect behavior   (MGI Ref ID J:147420)
    • behavioral despair
      • increased latency to float in a forced swimming test   (MGI Ref ID J:147420)
      • reduced despair behavior   (MGI Ref ID J:147420)
    • increased anxiety-related response
      • more time in the closed arms of an elevated + maze after forced swimming tests   (MGI Ref ID J:147420)
  • abnormal learning/memory/conditioning   (MGI Ref ID J:147420)
    • abnormal object recognition memory
      • reduced exploration in initial phase of novel object recognition tests   (MGI Ref ID J:147420)
      • increased exploration in novel object recognition tests   (MGI Ref ID J:148881)
      • abnormal long term object recognition memory
        • reduced object recognition when retested   (MGI Ref ID J:147420)
        • greater object recognition memory   (MGI Ref ID J:148881)
    • abnormal spatial learning
      • longer escape latencies in a Morris water maze   (MGI Ref ID J:147420)
      • shorter time spent in the target quadrant of a Morris water maze   (MGI Ref ID J:147420)
      • slower to relocate platform after it is moved   (MGI Ref ID J:147420)
  • nervous system phenotype
  • abnormal CNS glial cell morphology   (MGI Ref ID J:79142)
    • abnormal astrocyte morphology
      • density fails to increase in response to neurotoxin (6-OHDA) lesioning   (MGI Ref ID J:79142)
    • abnormal microglial cell morphology
      • modest increase in microglial density after haloperidol treatment relative to the increase seen in controls   (MGI Ref ID J:79142)
  • abnormal brain interneuron morphology
    • parvalbumin positive interneurons in the hippocampus suffer less loss in numbers with age   (MGI Ref ID J:148881)
  • abnormal nervous system physiology   (MGI Ref ID J:148881)
    • abnormal neuron physiology
      • age induced increase in oxygen consumption in synaptosomes is attenuated   (MGI Ref ID J:148881)
  • abnormal neuron morphology   (MGI Ref ID J:79142)
    • abnormal axon morphology
      • axon terminal tree is 25% larger in the substantia nigra pars compacta than for controls   (MGI Ref ID J:79142)
      • resistant to the effects of haloperidol treatment on terminal trees   (MGI Ref ID J:79142)
      • neurotoxin lesion results in reduced terminal tree density   (MGI Ref ID J:79142)
  • muscle phenotype
  • abnormal muscle precursor cell migration
    • migration of primary myoblasts is reduced relative to controls   (MGI Ref ID J:131016)
  • abnormal skeletal muscle fiber morphology
    • cross-sectional area of myofibers does not increase after overload of the plantaris muscle by incapacitation of the gastrocnemius, measured 14 and 42 days after overload   (MGI Ref ID J:131016)
    • no change in myonuclear numbers   (MGI Ref ID J:131016)
  • abnormal skeletal muscle satellite cell proliferation
    • proliferation is defective   (MGI Ref ID J:131016)
  • decreased cardiac muscle contractility
    • both fractional shortening and ejection fraction are decreased in adults and at 5 and 15 days of age   (MGI Ref ID J:150895)
    • cardiac dysfunction beginning at 15 days of age   (MGI Ref ID J:150895)
    • cardiac dilation is more or less normal at 5 days of age   (MGI Ref ID J:150895)
  • vision/eye phenotype
  • retinal outer nuclear layer degeneration
    • higher level of apoptosis after retinal separation from the retinal pigment epithelium   (MGI Ref ID J:136895)
    • higher rate of photoreceptor cell death after 1 month   (MGI Ref ID J:136895)
  • skeleton phenotype
  • abnormal bone healing
    • callus formed after bone fracture is denser after 2 weeks than is true in controls   (MGI Ref ID J:141482)
    • tissue mineral density is less at 4 and 6 weeks after injury than for controls   (MGI Ref ID J:141482)
    • greater collagen content at 2 weeks after fracture but not at 4 or 6 weeks   (MGI Ref ID J:141482)
  • decreased bone mineral density
    • mineral density of cortical bone reduced   (MGI Ref ID J:141482)
    • reduced crystallinity relative to controls   (MGI Ref ID J:141482)
    • reduced mineral/matrix ratio in cortical bone at both 2 and 4 weeks   (MGI Ref ID J:141482)
  • tumorigenesis
  • decreased incidence of tumors by chemical induction
    • reduced incidence of hepatocellular cancer in males treated with diethyl nitrosamine relative to incidence in control males   (MGI Ref ID J:122816)
  • liver/biliary system phenotype
  • hepatic necrosis
    • less necrosis resulting from diethyl nitrosamine treatment   (MGI Ref ID J:122816)
  • liver degeneration
    • less hepatic injury in males from treatment with diethyl nitrosamine   (MGI Ref ID J:122816)
    • less apoptosis due to diethyl nitrosamine treatment   (MGI Ref ID J:122816)
    • less compensatory proliferation as a result of diethyl nitrosamine treatment   (MGI Ref ID J:122816)
  • respiratory system phenotype
  • abnormal pulmonary gas exchange
    • elevated respiratory exchange rate in young mice   (MGI Ref ID J:105633)
  • homeostasis/metabolism phenotype
  • abnormal bone healing
    • callus formed after bone fracture is denser after 2 weeks than is true in controls   (MGI Ref ID J:141482)
    • tissue mineral density is less at 4 and 6 weeks after injury than for controls   (MGI Ref ID J:141482)
    • greater collagen content at 2 weeks after fracture but not at 4 or 6 weeks   (MGI Ref ID J:141482)
  • abnormal exercise endurance
    • reduced treadmill endurance   (MGI Ref ID J:105633)
  • abnormal homeostasis   (MGI Ref ID J:105633)
    • abnormal acute phase protein level
      • 100-fold reduction in SAA production by the liver in response to turpentine injection or listeria infection   (MGI Ref ID J:17360)
    • abnormal oxygen consumption
      • oxygen consumption is not maintained at as high a level after 12 minutes of running as in controls   (MGI Ref ID J:105633)
    • increased circulating glucose level
      • elevated basal glucose levels at 8 months but not in younger mice   (MGI Ref ID J:105633)
      • glucose levels do not differ from controls in young mice after 1 hour of exercise   (MGI Ref ID J:105633)
  • decreased incidence of tumors by chemical induction
    • reduced incidence of hepatocellular cancer in males treated with diethyl nitrosamine relative to incidence in control males   (MGI Ref ID J:122816)
  • endocrine/exocrine gland phenotype
  • abnormal involution of the mammary gland
    • develops more slowly   (MGI Ref ID J:125449)
  • digestive/alimentary phenotype
  • increased susceptibility to induced colitis
    • severe erosion of the intestinal epithelium from exposure to 3.5% dextran sodium sulfate   (MGI Ref ID J:79073)
  • integument phenotype
  • abnormal involution of the mammary gland
    • develops more slowly   (MGI Ref ID J:125449)
  • cellular phenotype
  • abnormal muscle precursor cell migration
    • migration of primary myoblasts is reduced relative to controls   (MGI Ref ID J:131016)
  • abnormal skeletal muscle satellite cell proliferation
    • proliferation is defective   (MGI Ref ID J:131016)

The following phenotype information is associated with a similar, but not exact match to this JAX® Mice strain.


  • immune system phenotype
  • abnormal interleukin-6 secretion
    • intraperitoneal administration of LPS does not induce production of Il6 in the livers of mutants compared to wild-type where expression is increase   (MGI Ref ID J:109359)
  • decreased interferon-gamma secretion
    • after restimulation of spleen cells with keyhole limpet hemocyanin one week following immunization of mutant mice, reduced interferon gamma production is observed   (MGI Ref ID J:123351)
  • decreased pro-B cell number
    • the percentage of CD19+ B cell progenitors in the bone marrow is decreased from 58% to 35%   (MGI Ref ID J:117320)
  • decreased susceptibility to induced arthritis
    • mice treated with collagen II exhibit a lack of disease incident with normal joints compared with wild-type mice   (MGI Ref ID J:208213)
  • increased interleukin-4 secretion
    • after restimulation of spleen cells with keyhole limpet hemocyanin one week following immunization of mutant mice, enhanced Il-4 secretion is observed   (MGI Ref ID J:123351)
  • homeostasis/metabolism phenotype
  • abnormal glucose homeostasis
    • inhibition of hepatic glucose production by ICV infusion of insulin is attenuated   (MGI Ref ID J:109359)
    • inhibition of hepatic glucose production assessed by a euglycemic hyperinsulinemic clamp is also attenuated   (MGI Ref ID J:109359)
    • decreased glucagon secretion
      • decreased fasting glucagon levels on a high fat diet   (MGI Ref ID J:139138)
    • decreased insulin secretion
      • decreased fasting insulin levels on a high fat diet   (MGI Ref ID J:139138)
    • impaired glucose tolerance
      • impaired glucose tolerance on a high fat diet   (MGI Ref ID J:139138)
  • increased body temperature   (MGI Ref ID J:105279)
    • injection of Il1beta results in body temperature elevation by about 0.5C   (MGI Ref ID J:136166)
  • hematopoietic system phenotype
  • decreased pro-B cell number
    • the percentage of CD19+ B cell progenitors in the bone marrow is decreased from 58% to 35%   (MGI Ref ID J:117320)
  • behavior/neurological phenotype
  • abnormal emotion/affect behavior   (MGI Ref ID J:146951)
    • behavioral despair
      • increased latency to "give up" in a forced swim test   (MGI Ref ID J:146951)
    • increased anxiety-related response
      • less time spent in the illuminated areas of a light-dark box   (MGI Ref ID J:146951)
      • significantly decreased time spent in the open arms of an elevated maze   (MGI Ref ID J:96218)
      • significantly decreased number of entries into the open arms of an elevated maze   (MGI Ref ID J:96218)
    • increased fear-related response
      • lower latency to escape adverse stimuli   (MGI Ref ID J:146951)
      • fewer failures to escape adverse stimuli   (MGI Ref ID J:146951)
  • abnormal sleep pattern
    • injection of Il1beta results in reduced dark phase wakefulness   (MGI Ref ID J:136166)
    • injection of Il1beta results in increased non REM sleep   (MGI Ref ID J:136166)
    • increased time in non-REM sleep after sleep deprivation persists longer than for controls but increase in time is equivalent   (MGI Ref ID J:105279)
    • abnormal frequency of paradoxical sleep
      • 30% increased time in REM sleep over a 24 hour period   (MGI Ref ID J:105279)
      • most extra REM sleep occurs in the light cycle   (MGI Ref ID J:105279)
      • length of REM bouts is normal but number of bouts increases   (MGI Ref ID J:105279)
  • hyperactivity
    • increased locomotor activity in open field tests   (MGI Ref ID J:96218)
  • endocrine/exocrine gland phenotype
  • abnormal pancreatic alpha cell morphology
    • alpha cell mass fails to increase on a high fat diet as it does in controls   (MGI Ref ID J:139138)
  • decreased glucagon secretion
    • decreased fasting glucagon levels on a high fat diet   (MGI Ref ID J:139138)
  • decreased insulin secretion
    • decreased fasting insulin levels on a high fat diet   (MGI Ref ID J:139138)
  • skeleton phenotype
  • decreased susceptibility to induced arthritis
    • mice treated with collagen II exhibit a lack of disease incident with normal joints compared with wild-type mice   (MGI Ref ID J:208213)


        involves: 129S2/SvPas
  • mortality/aging
  • increased susceptibility to bacterial infection induced morbidity/mortality
    • 60% mortality at day 12 after inoculation with C. rodentium   (MGI Ref ID J:161073)
  • immune system phenotype
  • abnormal T cell physiology
    • mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit impaired T cells (including CD4+, Th1, and Th17 cells) recruitment and production of IL17a compared with similarly treated wild-type mice   (MGI Ref ID J:159479)
  • abnormal inflammatory response
    • following carrageenan induced inflammation, mice exhibit impaired neutrophil resolution after 7 days and delayed macrophage infiltration compared to in similarly treated wild-type mice   (MGI Ref ID J:160966)
  • decreased interleukin-17 secretion
    • mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit fewer IL17a producing cells compared to in similarly treated wild-type mice   (MGI Ref ID J:159479)
  • increased susceptibility to bacterial infection induced morbidity/mortality
    • 60% mortality at day 12 after inoculation with C. rodentium   (MGI Ref ID J:161073)
  • homeostasis/metabolism phenotype
  • decreased susceptibility to injury
    • following exposure to acid-induced acute lung injury, mice exhibit alleviated symptoms compared to wild-type mice   (MGI Ref ID J:145306)
    • 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice   (MGI Ref ID J:89814)
  • delayed wound healing
    • at healing wounds, mice exhibit delayed re-epithelialization, formation of granulation tissue, macrophage infiltration, fibrin clearance, and vascularization compared with wild-type mice   (MGI Ref ID J:160966)
  • impaired wound healing
    • wounds become expanded beyond the boundaries of the original wound unlike in wild-type mice   (MGI Ref ID J:160966)
  • liver/biliary system phenotype
  • abnormal oval cell physiology
    • modestly reduced oval cell response to a choline deficient diet and ethionine in the drinking water   (MGI Ref ID J:66448)
  • nervous system phenotype
  • abnormal glial cell morphology
    • 24 hours after scalpel cortex injury, mice exhibit reduced microglial and astrocyte reaction compared with similarly treated wild-type mice   (MGI Ref ID J:89814)
  • hematopoietic system phenotype
  • abnormal T cell physiology
    • mice challenged with Staphylococcus epidermidis cell-free supernatant exhibit impaired T cells (including CD4+, Th1, and Th17 cells) recruitment and production of IL17a compared with similarly treated wild-type mice   (MGI Ref ID J:159479)


        involves: 129S2/SvPas * C57BL/6J * CE/J
  • behavior/neurological phenotype
  • seizures
    • a substantial proportion of homozygotes develop generalized seizures after 250 days of age   (MGI Ref ID J:63197)
  • nervous system phenotype
  • seizures
    • a substantial proportion of homozygotes develop generalized seizures after 250 days of age   (MGI Ref ID J:63197)
View Research Applications

Research Applications
This mouse can be used to support research in many areas including:

Cancer Research
Growth Factors/Receptors/Cytokines

Hematological Research
Immunological Defects

Immunology, Inflammation and Autoimmunity Research
      experimental allergic encephalomyelitis (EAE)
CD Antigens, Antigen Receptors, and Histocompatibility Markers
      genes regulating susceptibility to infectious disease and endotoxin
Growth Factors/Receptors/Cytokines
Intracellular Signaling Molecules
Lymphoid Tissue Defects

Internal/Organ Research
Lymphoid Tissue Defects
Wound Healing

Research Tools
Cancer Research
Immunology, Inflammation and Autoimmunity Research
      genes regulating susceptibility to infectious disease and endotoxin

Il6tm1Kopf related

Cancer Research
Growth Factors/Receptors/Cytokines

Immunology, Inflammation and Autoimmunity Research
Growth Factors/Receptors/Cytokines

Genes & Alleles

Gene & Allele Information provided by MGI

Allele Symbol Il6tm1Kopf
Allele Name targeted mutation 1, Manfred Kopf
Allele Type Targeted (Null/Knockout)
Common Name(s) IL-6 KO; IL-6-; Il6-; Il6tm1Koe; Il6tm1Kopf;
Mutation Made ByDr. Manfred Kopf,   ETH Zurich
Strain of Origin129S2/SvPas
ES Cell Line NameD3
ES Cell Line Strain129S2/SvPas
Gene Symbol and Name Il6, interleukin 6
Chromosome 5
Gene Common Name(s) BSF2; HGF; HSF; IFNB2; IL-6; ILg6; Il-6;
Molecular Note A neomycin selection cassette was inserted into exon 2. RT-PCR experiments on RNA derived from LPS-stimulated macrophages of homozygous mice demonstrated that no detectable transcript was produced from this allele. ELISA and bioassay experiments confirmed that no functional protein was made in homozygous mice. [MGI Ref ID J:17360]


Genotyping Information

Genotyping Protocols

Il6tm1Kopf MCA, MELT
Il6tm1Kopf, Standard PCR

Helpful Links

Genotyping resources and troubleshooting


References provided by MGI

Selected Reference(s)

Kopf M; Baumann H; Freer G; Freudenberg M; Lamers M; Kishimoto T; Zinkernagel R; Bluethmann H; Kohler G. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368(6469):339-42. [PubMed: 8127368]  [MGI Ref ID J:17360]

Additional References

Cole N; Krockenberger M; Bao S; Beagley KW; Husband AJ; Willcox M. 2001. Effects of Exogenous Interleukin-6 during Pseudomonas aeruginosa Corneal Infection. Infect Immun 69(6):4116-9. [PubMed: 11349084]  [MGI Ref ID J:69543]

Gallucci RM; Simeonova PP; Matheson JM; Kommineni C; Guriel JL; Sugawara T; Luster MI. 2000. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice FASEB J 14(15):2525-31. [PubMed: 11099471]  [MGI Ref ID J:66089]

Hilbert DM; Kopf M; Mock BA; Kohler G; Rudikoff S. 1995. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med 182(1):243-8. [PubMed: 7790819]  [MGI Ref ID J:26249]

Lin T; Bost KL. 2004. STAT3 activation in macrophages following infection with Salmonella. Biochem Biophys Res Commun 321(4):828-34. [PubMed: 15358102]  [MGI Ref ID J:91740]

Wang Q; Fang CH; Hasselgren PO. 2001. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281(3):R1013-23. [PubMed: 11507020]  [MGI Ref ID J:71507]

van der Poll T; Keogh CV; Guirao X; Buurman WA; Kopf M; Lowry SF. 1997. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176(2):439-44. [PubMed: 9237710]  [MGI Ref ID J:41791]

Il6tm1Kopf related

Akasheh RT; Pini M; Pang J; Fantuzzi G. 2013. Increased adiposity in annexin A1-deficient mice. PLoS One 8(12):e82608. [PubMed: 24312665]  [MGI Ref ID J:209746]

Ancrile B; Lim KH; Counter CM. 2007. Oncogenic Ras-induced secretion of IL6 is required for tumorigenesis. Genes Dev 21(14):1714-9. [PubMed: 17639077]  [MGI Ref ID J:123152]

Andris F; Denanglaire S; Baus E; Rongvaux A; Steuve J; Flavell RA; Leo O. 2011. Metabolic stress boosts humoral responses in vivo independently of inflammasome and inflammatory reaction. J Immunol 186(4):2245-53. [PubMed: 21248260]  [MGI Ref ID J:169140]

Angeli V; Faveeuw C; Delerive P; Fontaine J; Barriera Y; Franchimont N; Staels B; Capron M; Trottein F. 2001. Schistosoma mansoni induces the synthesis of IL-6 in pulmonary microvascular endothelial cells: role of IL-6 in the control of lung eosinophilia during infection. Eur J Immunol 31(9):2751-61. [PubMed: 11536174]  [MGI Ref ID J:71675]

Anguita J; Rincon M; Samanta S; Barthold SW; Flavell RA; Fikrig E. 1998. Borrelia burgdorferi-infected, interleukin-6-deficient mice have decreased Th2 responses and increased lyme arthritis. J Infect Dis 178(5):1512-5. [PubMed: 9780277]  [MGI Ref ID J:51191]

Ankathatti Munegowda M; Xu S; Freywald A; Xiang J. 2012. CD4+ Th2 cells function alike effector Tr1 and Th1 cells through the deletion of a single cytokine IL-6 and IL-10 gene. Mol Immunol 51(2):143-9. [PubMed: 22424785]  [MGI Ref ID J:184874]

Aoki R; Kawamura T; Goshima F; Ogawa Y; Nakae S; Nakao A; Moriishi K; Nishiyama Y; Shimada S. 2013. Mast Cells Play a Key Role in Host Defense against Herpes Simplex Virus Infection through TNF-alpha and IL-6 Production. J Invest Dermatol 133(9):2170-9. [PubMed: 23528820]  [MGI Ref ID J:200049]

Arac A; Grimbaldeston MA; Nepomuceno AR; Olayiwola O; Pereira MP; Nishiyama Y; Tsykin A; Goodall GJ; Schlecht U; Vogel H; Tsai M; Galli SJ; Bliss TM; Steinberg GK. 2014. Evidence that meningeal mast cells can worsen stroke pathology in mice. Am J Pathol 184(9):2493-504. [PubMed: 25134760]  [MGI Ref ID J:214825]

Arima Y; Harada M; Kamimura D; Park JH; Kawano F; Yull FE; Kawamoto T; Iwakura Y; Betz UA; Marquez G; Blackwell TS; Ohira Y; Hirano T; Murakami M. 2012. Regional neural activation defines a gateway for autoreactive T cells to cross the blood-brain barrier. Cell 148(3):447-57. [PubMed: 22304915]  [MGI Ref ID J:181336]

Armario A; Hernandez J; Bluethmann H; Hidalgo J. 1998. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. J Neuroimmunol 92(1-2):160-9. [PubMed: 9916891]  [MGI Ref ID J:53626]

Arocena AR; Onofrio LI; Pellegrini AV; Carrera Silva AE; Paroli A; Cano RC; Aoki MP; Gea S. 2014. Myeloid-derived suppressor cells are key players in the resolution of inflammation during a model of acute infection. Eur J Immunol 44(1):184-94. [PubMed: 24166778]  [MGI Ref ID J:208911]

Arsenijevic D; Clavel S; Sanchis D; Plamondon J; Huang Q; Ricquier D; Rouger L; Richard D. 2007. Induction of Ucp2 expression in brain phagocytes and neurons following murine toxoplasmosis: an essential role of IFN-gamma and an association with negative energy balance. J Neuroimmunol 186(1-2):121-32. [PubMed: 17467814]  [MGI Ref ID J:124552]

Awazawa M; Ueki K; Inabe K; Yamauchi T; Kubota N; Kaneko K; Kobayashi M; Iwane A; Sasako T; Okazaki Y; Ohsugi M; Takamoto I; Yamashita S; Asahara H; Akira S; Kasuga M; Kadowaki T. 2011. Adiponectin enhances insulin sensitivity by increasing hepatic IRS-2 expression via a macrophage-derived IL-6-dependent pathway. Cell Metab 13(4):401-12. [PubMed: 21459325]  [MGI Ref ID J:172246]

Baban B; Chandler PR; Sharma MD; Pihkala J; Koni PA; Munn DH; Mellor AL. 2009. IDO activates regulatory T cells and blocks their conversion into Th17-like T cells. J Immunol 183(4):2475-83. [PubMed: 19635913]  [MGI Ref ID J:151475]

Bai Y; Liu R; Huang D; La Cava A; Tang YY; Iwakura Y; Campagnolo DI; Vollmer TL; Ransohoff RM; Shi FD. 2008. CCL2 recruitment of IL-6-producing CD11b(+) monocytes to the draining lymph nodes during the initiation of Th17-dependent B cell-mediated autoimmunity. Eur J Immunol 38(7):1877-88. [PubMed: 18581322]  [MGI Ref ID J:137386]

Baier PC; May U; Scheller J; Rose-John S; Schiffelholz T. 2009. Impaired hippocampus-dependent and -independent learning in IL-6 deficient mice. Behav Brain Res 200(1):192-6. [PubMed: 19378383]  [MGI Ref ID J:147420]

Baltgalvis KA; Berger FG; Pena MM; Davis JM; Muga SJ; Carson JA. 2008. Interleukin-6 and cachexia in ApcMin/+ mice. Am J Physiol Regul Integr Comp Physiol 294(2):R393-401. [PubMed: 18056981]  [MGI Ref ID J:130429]

Banaiee N; Kincaid EZ; Buchwald U; Jacobs WR Jr; Ernst JD. 2006. Potent inhibition of macrophage responses to IFN-gamma by live virulent Mycobacterium tuberculosis is independent of mature mycobacterial lipoproteins but dependent on TLR2. J Immunol 176(5):3019-27. [PubMed: 16493060]  [MGI Ref ID J:129417]

Banerjee I; Fuseler JW; Intwala AR; Baudino TA. 2009. IL-6 loss causes ventricular dysfunction, fibrosis, reduced capillary density, and dramatically alters the cell populations of the developing and adult heart. Am J Physiol Heart Circ Physiol 296(5):H1694-704. [PubMed: 19234091]  [MGI Ref ID J:150895]

Bao S; Husband AJ; Beagley KW. 1999. B1 B cell numbers and antibodies against phosphorylcholine and LPS are increased in IL-6 gene knockout mice. Cell Immunol 198(2):139-42. [PubMed: 10648128]  [MGI Ref ID J:60275]

Barber DL; Andrade BB; McBerry C; Sereti I; Sher A. 2014. Role of IL-6 in Mycobacterium avium--associated immune reconstitution inflammatory syndrome. J Immunol 192(2):676-82. [PubMed: 24337386]  [MGI Ref ID J:207328]

Barnes TM; Otero YF; Elliott AD; Locke AD; Malabanan CM; Coldren AG; Brissova M; Piston DW; McGuinness OP. 2014. Interleukin-6 amplifies glucagon secretion: coordinated control via the brain and pancreas. Am J Physiol Endocrinol Metab 307(10):E896-905. [PubMed: 25205821]  [MGI Ref ID J:217822]

Barr TA; Brown S; Mastroeni P; Gray D. 2010. TLR and B cell receptor signals to B cells differentially program primary and memory Th1 responses to Salmonella enterica. J Immunol 185(5):2783-9. [PubMed: 20675594]  [MGI Ref ID J:163256]

Basu R; O'Quinn DB; Silberger DJ; Schoeb TR; Fouser L; Ouyang W; Hatton RD; Weaver CT. 2012. Th22 Cells Are an Important Source of IL-22 for Host Protection against Enteropathogenic Bacteria. Immunity 37(6):1061-75. [PubMed: 23200827]  [MGI Ref ID J:191059]

Basu S; Hodgson G; Zhang HH; Katz M; Quilici C; Dunn AR. 2000. 'Emergency' granulopoiesis in G-CSF-deficient mice in response to candida albicans infection Blood 95(12):3725-33. [PubMed: 10845903]  [MGI Ref ID J:63085]

Beenhouwer DO; Shapiro S; Feldmesser M; Casadevall A; Scharff MD. 2001. Both Th1 and Th2 Cytokines Affect the Ability of Monoclonal Antibodies To Protect Mice against Cryptococcus neoformans. Infect Immun 69(10):6445-55. [PubMed: 11553589]  [MGI Ref ID J:71570]

Behrens MM; Ali SS; Dugan LL. 2008. Interleukin-6 mediates the increase in NADPH-oxidase in the ketamine model of schizophrenia. J Neurosci 28(51):13957-66. [PubMed: 19091984]  [MGI Ref ID J:143515]

Benrick A; Schele E; Pinnock SB; Wernstedt-Asterholm I; Dickson SL; Karlsson-Lindahl L; Jansson JO. 2009. Interleukin-6 gene knockout influences energy balance regulating peptides in the hypothalamic paraventricular and supraoptic nuclei. J Neuroendocrinol 21(7):620-8. [PubMed: 19490366]  [MGI Ref ID J:165764]

Bernad A; Kopf M; Kulbacki R; Weich N; Koehler G; Gutierrez-Ramos JC. 1994. Interleukin-6 is required in vivo for the regulation of stem cells and committed progenitors of the hematopoietic system. Immunity 1(9):725-31. [PubMed: 7895162]  [MGI Ref ID J:126683]

Besson-Fournier C; Latour C; Kautz L; Bertrand J; Ganz T; Roth MP; Coppin H. 2012. Induction of activin B by inflammatory stimuli up-regulates expression of the iron-regulatory peptide hepcidin through Smad1/5/8 signaling. Blood 120(2):431-9. [PubMed: 22611157]  [MGI Ref ID J:189128]

Bethin KE; Vogt SK; Muglia LJ. 2000. Interleukin-6 is an essential, corticotropin-releasing hormone-independent stimulator of the adrenal axis during immune system activation. Proc Natl Acad Sci U S A 97(16):9317-22. [PubMed: 10922080]  [MGI Ref ID J:126698]

Beury DW; Parker KH; Nyandjo M; Sinha P; Carter KA; Ostrand-Rosenberg S. 2014. Cross-talk among myeloid-derived suppressor cells, macrophages, and tumor cells impacts the inflammatory milieu of solid tumors. J Leukoc Biol 96(6):1109-18. [PubMed: 25170116]  [MGI Ref ID J:220098]

Bleier JI; Pillarisetty VG; Shah AB; DeMatteo RP. 2004. Increased and long-term generation of dendritic cells with reduced function from IL-6-deficient bone marrow. J Immunol 172(12):7408-16. [PubMed: 15187118]  [MGI Ref ID J:90835]

Blindenbacher A; Wang X; Langer I; Savino R; Terracciano L; Heim MH. 2003. Interleukin 6 is important for survival after partial hepatectomy in mice. Hepatology 38(3):674-82. [PubMed: 12939594]  [MGI Ref ID J:105919]

Boe A; Baiocchi M; Carbonatto M; Papoian R; Serlupi-Crescenzi O. 1999. Interleukin 6 knock-out mice are resistant to antigen-induced experimental arthritis. Cytokine 11(12):1057-64. [PubMed: 10623431]  [MGI Ref ID J:102632]

Boelen A; Maas MA; Lowik CW; Platvoet MC; Wiersinga WM. 1996. Induced illness in interleukin-6 (IL-6) knock-out mice: a causal role of IL-6 in the development of the low 3,5,3'-triiodothyronine syndrome. Endocrinology 137(12):5250-4. [PubMed: 8940342]  [MGI Ref ID J:37227]

Boesen EI; Pollock DM. 2007. Effect of chronic IL-6 infusion on acute pressor responses to vasoconstrictors in mice. Am J Physiol Heart Circ Physiol 293(3):H1745-9. [PubMed: 17557918]  [MGI Ref ID J:126152]

Bollrath J; Phesse TJ; von Burstin VA; Putoczki T; Bennecke M; Bateman T; Nebelsiek T; Lundgren-May T; Canli O; Schwitalla S; Matthews V; Schmid RM; Kirchner T; Arkan MC; Ernst M; Greten FR. 2009. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell 15(2):91-102. [PubMed: 19185844]  [MGI Ref ID J:144814]

Bonetto A; Aydogdu T; Jin X; Zhang Z; Zhan R; Puzis L; Koniaris LG; Zimmers TA. 2012. JAK/STAT3 pathway inhibition blocks skeletal muscle wasting downstream of IL-6 and in experimental cancer cachexia. Am J Physiol Endocrinol Metab 303(3):E410-21. [PubMed: 22669242]  [MGI Ref ID J:187289]

Booth AJ; Grabauskiene S; Wood SC; Lu G; Burrell BE; Bishop DK. 2011. IL-6 promotes cardiac graft rejection mediated by CD4+ cells. J Immunol 187(11):5764-71. [PubMed: 22025555]  [MGI Ref ID J:179767]

Bopst M; Haas C; Car B; Eugster HP. 1998. The combined inactivation of tumor necrosis factor and interleukin-6 prevents induction of the major acute phase proteins by endotoxin. Eur J Immunol 28(12):4130-7. [PubMed: 9862349]  [MGI Ref ID J:77684]

Botelho FM; Rangel-Moreno J; Fritz D; Randall TD; Xing Z; Richards CD. 2013. Pulmonary expression of oncostatin M (OSM) promotes inducible BALT formation independently of IL-6, despite a role for IL-6 in OSM-driven pulmonary inflammation. J Immunol 191(3):1453-64. [PubMed: 23797667]  [MGI Ref ID J:205732]

Brender C; Tannahill GM; Jenkins BJ; Fletcher J; Columbus R; Saris CJ; Ernst M; Nicola NA; Hilton DJ; Alexander WS; Starr R. 2007. Suppressor of cytokine signaling 3 regulates CD8 T-cell proliferation by inhibition of interleukins 6 and 27. Blood 110(7):2528-36. [PubMed: 17609432]  [MGI Ref ID J:147013]

Brewer JA; Bethin KE; Schaefer ML; Muglia LM; Vogt SK; Weninger SC; Majzoub JA; Muglia LJ. 2003. Dissecting adrenal and behavioral responses to stress by targeted gene inactivation in mice. Stress 6(2):121-5. [PubMed: 12775331]  [MGI Ref ID J:97729]

Bromander AK; Ekman L; Kopf M; Nedrud JG; Lycke NY. 1996. IL-6-deficient mice exhibit normal mucosal IgA responses to local immunizations and Helicobacter felis infection. J Immunol 156(11):4290-7. [PubMed: 8666800]  [MGI Ref ID J:110823]

Budinger GR; McKell JL; Urich D; Foiles N; Weiss I; Chiarella SE; Gonzalez A; Soberanes S; Ghio AJ; Nigdelioglu R; Mutlu EA; Radigan KA; Green D; Kwaan HC; Mutlu GM. 2011. Particulate matter-induced lung inflammation increases systemic levels of PAI-1 and activates coagulation through distinct mechanisms. PLoS One 6(4):e18525. [PubMed: 21494547]  [MGI Ref ID J:172227]

Butterweck V; Prinz S; Schwaninger M. 2003. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice. Behav Brain Res 144(1-2):49-56. [PubMed: 12946594]  [MGI Ref ID J:96218]

Cafferty WB; Gardiner NJ; Das P; Qiu J; McMahon SB; Thompson SW. 2004. Conditioning injury-induced spinal axon regeneration fails in interleukin-6 knock-out mice. J Neurosci 24(18):4432-43. [PubMed: 15128857]  [MGI Ref ID J:96878]

Cao W; Yang Y; Wang Z; Liu A; Fang L; Wu F; Hong J; Shi Y; Leung S; Dong C; Zhang JZ. 2011. Leukemia inhibitory factor inhibits T helper 17 cell differentiation and confers treatment effects of neural progenitor cell therapy in autoimmune disease. Immunity 35(2):273-84. [PubMed: 21835648]  [MGI Ref ID J:176067]

Cao Z; Gao Y; Bryson JB; Hou J; Chaudhry N; Siddiq M; Martinez J; Spencer T; Carmel J; Hart RB; Filbin MT. 2006. The cytokine interleukin-6 is sufficient but not necessary to mimic the peripheral conditioning lesion effect on axonal growth. J Neurosci 26(20):5565-73. [PubMed: 16707807]  [MGI Ref ID J:144901]

Carow B; Reuschl AK; Gavier-Widen D; Jenkins BJ; Ernst M; Yoshimura A; Chambers BJ; Rottenberg ME. 2013. Critical and independent role for SOCS3 in either myeloid or T cells in resistance to Mycobacterium tuberculosis. PLoS Pathog 9(7):e1003442. [PubMed: 23853585]  [MGI Ref ID J:213369]

Carrasco J; Hernandez J; Bluethmann H; Hidalgo J. 1998. Interleukin-6 and tumor necrosis factor-alpha type 1 receptor deficient mice reveal a role of IL-6 and TNF-alpha on brain metallothionein-I and -III regulation. Brain Res Mol Brain Res 57(2):221-34. [PubMed: 9675420]  [MGI Ref ID J:48525]

Cenci E; Mencacci A; Casagrande A; Mosci P; Bistoni F; Romani L. 2001. Impaired antifungal effector activity but not inflammatory cell recruitment in interleukin-6-deficient mice with invasive pulmonary aspergillosis. J Infect Dis 184(5):610-7. [PubMed: 11494166]  [MGI Ref ID J:120152]

Chang EY; Guo B; Doyle SE; Cheng G. 2007. Cutting edge: involvement of the type I IFN production and signaling pathway in lipopolysaccharide-induced IL-10 production. J Immunol 178(11):6705-9. [PubMed: 17513714]  [MGI Ref ID J:147854]

Chang L; Guo R; Huang Q; Yen Y. 2013. Chromosomal instability triggered by Rrm2b loss leads to IL-6 secretion and plasmacytic neoplasms. Cell Rep 3(5):1389-97. [PubMed: 23643536]  [MGI Ref ID J:198487]

Chen Q; Fisher DT; Clancy KA; Gauguet JM; Wang WC; Unger E; Rose-John S; von Andrian UH; Baumann H; Evans SS. 2006. Fever-range thermal stress promotes lymphocyte trafficking across high endothelial venules via an interleukin 6 trans-signaling mechanism. Nat Immunol 7(12):1299-1308. [PubMed: 17086187]  [MGI Ref ID J:116128]

Chida D; Imaki T; Suda T; Iwakura Y. 2005. Involvement of corticotropin-releasing hormone- and interleukin (IL)-6-dependent proopiomelanocortin induction in the anterior pituitary during hypothalamic-pituitary-adrenal axis activation by IL-1alpha. Endocrinology 146(12):5496-502. [PubMed: 16141396]  [MGI Ref ID J:129687]

Chida D; Iwakura Y. 2007. Peripheral TNFalpha, but not peripheral IL-1, requires endogenous IL-1 or TNFalpha induction in the brain for the febrile response. Biochem Biophys Res Commun 364(4):765-70. [PubMed: 17967442]  [MGI Ref ID J:128436]

Chida D; Osaka T; Hashimoto O; Iwakura Y. 2006. Combined interleukin-6 and interleukin-1 deficiency causes obesity in young mice. Diabetes 55(4):971-7. [PubMed: 16567518]  [MGI Ref ID J:108607]

Chida Y; Sudo N; Motomura Y; Kubo C. 2004. Electric foot-shock stress drives TNF-alpha production in the liver of IL-6-deficient mice. Neuroimmunomodulation 11(6):419-24. [PubMed: 15467358]  [MGI Ref ID J:105444]

Ching S; He L; Lai W; Quan N. 2005. IL-1 type I receptor plays a key role in mediating the recruitment of leukocytes into the central nervous system. Brain Behav Immun 19(2):127-37. [PubMed: 15664785]  [MGI Ref ID J:105351]

Cho J; Kim L; Li Z; Rose NR; Talor MV; Njoku DB. 2013. Sex bias in experimental immune-mediated, drug-induced liver injury in BALB/c mice: suggested roles for tregs, estrogen, and IL-6. PLoS One 8(4):e61186. [PubMed: 23577207]  [MGI Ref ID J:200587]

Cho SW; Pirih FQ; Koh AJ; Michalski M; Eber MR; Ritchie K; Sinder B; Oh S; Al-Dujaili SA; Lee J; Kozloff K; Danciu T; Wronski TJ; McCauley LK. 2013. The soluble interleukin-6 receptor is a mediator of hematopoietic and skeletal actions of parathyroid hormone. J Biol Chem 288(10):6814-25. [PubMed: 23297399]  [MGI Ref ID J:195999]

Choi YS; Eto D; Yang JA; Lao C; Crotty S. 2013. Cutting Edge: STAT1 Is Required for IL-6-Mediated Bcl6 Induction for Early Follicular Helper Cell Differentiation. J Immunol 190(7):3049-53. [PubMed: 23447690]  [MGI Ref ID J:194834]

Chong DY; Boehlke CS; Zheng QD; Zhang L; Han Y; Zacks DN. 2008. Interleukin-6 as a photoreceptor neuroprotectant in an experimental model of retinal detachment. Invest Ophthalmol Vis Sci 49(7):3193-200. [PubMed: 18378582]  [MGI Ref ID J:136895]

Choudhury A; Cohen PL; Eisenberg RA. 2010. B cells require 'nurturing' by CD4 T cells during development in order to respond in chronic graft-versus-host model of systemic lupus erythematosus. Clin Immunol :. [PubMed: 20381429]  [MGI Ref ID J:160847]

Chourbaji S; Urani A; Inta I; Sanchis-Segura C; Brandwein C; Zink M; Schwaninger M; Gass P. 2006. IL-6 knockout mice exhibit resistance to stress-induced development of depression-like behaviors. Neurobiol Dis 23(3):587-94. [PubMed: 16843000]  [MGI Ref ID J:146951]

Coers J; Vance RE; Fontana MF; Dietrich WF. 2007. Restriction of Legionella pneumophila growth in macrophages requires the concerted action of cytokine and Naip5/Ipaf signalling pathways. Cell Microbiol 9(10):2344-57. [PubMed: 17506816]  [MGI Ref ID J:148669]

Coles B; Fielding CA; Rose-John S; Scheller J; Jones SA; O'Donnell VB. 2007. Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo. Am J Pathol 171(1):315-25. [PubMed: 17591976]  [MGI Ref ID J:122823]

Constante M; Wang D; Raymond VA; Bilodeau M; Santos MM. 2007. Repression of repulsive guidance molecule C during inflammation is independent of Hfe and involves tumor necrosis factor-alpha. Am J Pathol 170(2):497-504. [PubMed: 17255318]  [MGI Ref ID J:117889]

Coursey TG; Chen PW; Niederkorn JY. 2011. IL-17-dependent, IFN-gamma-independent tumor rejection is mediated by cytotoxic T lymphocytes and occurs at extraocular sites, but is excluded from the eye. J Immunol 187(8):4219-28. [PubMed: 21918192]  [MGI Ref ID J:179307]

Cui W; Joshi NS; Liu Y; Meng H; Kleinstein SH; Kaech SM. 2014. TLR4 ligands lipopolysaccharide and monophosphoryl lipid a differentially regulate effector and memory CD8+ T Cell differentiation. J Immunol 192(9):4221-32. [PubMed: 24659688]  [MGI Ref ID J:209988]

Cuzzone DA; Weitman ES; Albano NJ; Ghanta S; Savetsky IL; Gardenier JC; Joseph WJ; Torrisi JS; Bromberg JF; Olszewski WL; Rockson SG; Mehrara BJ. 2014. IL-6 regulates adipose deposition and homeostasis in lymphedema. Am J Physiol Heart Circ Physiol 306(10):H1426-34. [PubMed: 24633552]  [MGI Ref ID J:211549]

Dann SM; Spehlmann ME; Hammond DC; Iimura M; Hase K; Choi LJ; Hanson E; Eckmann L. 2008. IL-6-dependent mucosal protection prevents establishment of a microbial niche for attaching/effacing lesion-forming enteric bacterial pathogens. J Immunol 180(10):6816-26. [PubMed: 18453602]  [MGI Ref ID J:134871]

Darowish M; Rahman R; Li P; Bukata SV; Gelinas J; Huang W; Flick LM; Schwarz EM; O'Keefe RJ. 2009. Reduction of particle-induced osteolysis by interleukin-6 involves anti-inflammatory effect and inhibition of early osteoclast precursor differentiation. Bone 45(4):661-8. [PubMed: 19524707]  [MGI Ref ID J:154409]

Das LM; Rosenjack J; Au L; Galle PS; Hansen MB; Cathcart MK; McCormick TS; Cooper KD; Silverstein RL; Lu KQ. 2015. Hyper-inflammation and skin destruction mediated by rosiglitazone activation of macrophages in IL-6 deficiency. J Invest Dermatol 135(2):389-99. [PubMed: 25184961]  [MGI Ref ID J:217936]

Datta SK; Sabet M; Nguyen KP; Valdez PA; Gonzalez-Navajas JM; Islam S; Mihajlov I; Fierer J; Insel PA; Webster NJ; Guiney DG; Raz E. 2010. Mucosal adjuvant activity of cholera toxin requires Th17 cells and protects against inhalation anthrax. Proc Natl Acad Sci U S A 107(23):10638-43. [PubMed: 20479237]  [MGI Ref ID J:165056]

Dawicki W; Jawdat DW; Xu N; Marshall JS. 2010. Mast cells, histamine, and IL-6 regulate the selective influx of dendritic cell subsets into an inflamed lymph node. J Immunol 184(4):2116-23. [PubMed: 20083654]  [MGI Ref ID J:159485]

Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R. 2004. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2. Cardiovasc Res 64(1):61-71. [PubMed: 15364614]  [MGI Ref ID J:162844]

DeRoo EP; Wrobleski SK; Shea EM; Al-Khalil RK; Hawley AE; Henke PK; Myers DD Jr; Wakefield TW; Diaz JA. 2015. The role of galectin-3 and galectin-3-binding protein in venous thrombosis. Blood 125(11):1813-21. [PubMed: 25428218]  [MGI Ref ID J:221170]

Dedera DA; Urashima M; Chauhan D; LeBrun DP; Bronson RT; Anderson KC. 1996. Interleukin-6 is required for pristane-induced plasma cell hyperplasia in mice. Br J Haematol 94(1):53-6. [PubMed: 8757508]  [MGI Ref ID J:34203]

Deng C; Goluszko E; Tuzun E; Yang H; Christadoss P. 2002. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. J Immunol 169(2):1077-83. [PubMed: 12097416]  [MGI Ref ID J:123833]

Denkinger CM; Denkinger MD; Forsthuber TG. 2007. Pertussis toxin-induced cytokine differentiation and clonal expansion of T cells is mediated predominantly via costimulation. Cell Immunol 246(1):46-54. [PubMed: 17601518]  [MGI Ref ID J:123551]

Denzel A; Maus UA; Rodriguez Gomez M; Moll C; Niedermeier M; Winter C; Maus R; Hollingshead S; Briles DE; Kunz-Schughart LA; Talke Y; Mack M. 2008. Basophils enhance immunological memory responses. Nat Immunol 9(7):733-42. [PubMed: 18516038]  [MGI Ref ID J:137679]

Di Gregorio GB; Hensley L; Lu T; Ranganathan G; Kern PA. 2004. Lipid and carbohydrate metabolism in mice with a targeted mutation in the IL-6 gene: absence of development of age-related obesity. Am J Physiol Endocrinol Metab 287(1):E182-7. [PubMed: 15191885]  [MGI Ref ID J:95403]

Diao H; Kohanawa M. 2005. Endogenous interleukin-6 plays a crucial protective role in streptococcal toxic shock syndrome via suppression of tumor necrosis factor alpha production. Infect Immun 73(6):3745-8. [PubMed: 15908405]  [MGI Ref ID J:99141]

Dissanayake D; Hall H; Berg-Brown N; Elford AR; Hamilton SR; Murakami K; Deluca LS; Gommerman JL; Ohashi PS. 2011. Nuclear factor-kappaB1 controls the functional maturation of dendritic cells and prevents the activation of autoreactive T cells. Nat Med 17(12):1663-7. [PubMed: 22081022]  [MGI Ref ID J:180207]

Doisne JM; Becourt C; Amniai L; Duarte N; Le Luduec JB; Eberl G; Benlagha K. 2009. Skin and peripheral lymph node invariant NKT cells are mainly retinoic acid receptor-related orphan receptor (gamma)t+ and respond preferentially under inflammatory conditions. J Immunol 183(3):2142-9. [PubMed: 19587013]  [MGI Ref ID J:151705]

Dube PH; Handley SA; Lewis J; Miller VL. 2004. Protective role of interleukin-6 during Yersinia enterocolitica infection is mediated through the modulation of inflammatory cytokines. Infect Immun 72(6):3561-70. [PubMed: 15155665]  [MGI Ref ID J:90264]

Dugan LL; Ali SS; Shekhtman G; Roberts AJ; Lucero J; Quick KL; Behrens MM. 2009. IL-6 mediated degeneration of forebrain GABAergic interneurons and cognitive impairment in aged mice through activation of neuronal NADPH oxidase. PLoS ONE 4(5):e5518. [PubMed: 19436757]  [MGI Ref ID J:148881]

Eddahri F; Denanglaire S; Bureau F; Spolski R; Leonard WJ; Leo O; Andris F. 2009. Interleukin-6/STAT3 signaling regulates the ability of naive T cells to acquire B-cell help capacities. Blood 113(11):2426-33. [PubMed: 19020307]  [MGI Ref ID J:146334]

El Kasmi KC; Holst J; Coffre M; Mielke L; de Pauw A; Lhocine N; Smith AM; Rutschman R; Kaushal D; Shen Y; Suda T; Donnelly RP; Myers MG Jr; Alexander W; Vignali DA; Watowich SS; Ernst M; Hilton DJ; Murray PJ. 2006. General nature of the STAT3-activated anti-inflammatory response. J Immunol 177(11):7880-8. [PubMed: 17114459]  [MGI Ref ID J:140695]

Elhage R; Clamens S; Besnard S; Mallat Z; Tedgui A; Arnal J; Maret A; Bayard F. 2001. Involvement of interleukin-6 in atherosclerosis but not in the prevention of fatty streak formation by 17beta-estradiol in apolipoprotein E-deficient mice. Atherosclerosis 156(2):315-20. [PubMed: 11395027]  [MGI Ref ID J:81146]

Ellingsgaard H; Ehses JA; Hammar EB; Van Lommel L; Quintens R; Martens G; Kerr-Conte J; Pattou F; Berney T; Pipeleers D; Halban PA; Schuit FC; Donath MY. 2008. Interleukin-6 regulates pancreatic alpha-cell mass expansion. Proc Natl Acad Sci U S A 105(35):13163-8. [PubMed: 18719127]  [MGI Ref ID J:139138]

Ellingsgaard H; Hauselmann I; Schuler B; Habib AM; Baggio LL; Meier DT; Eppler E; Bouzakri K; Wueest S; Muller YD; Hansen AM; Reinecke M; Konrad D; Gassmann M; Reimann F; Halban PA; Gromada J; Drucker DJ; Gribble FM; Ehses JA; Donath MY. 2011. Interleukin-6 enhances insulin secretion by increasing glucagon-like peptide-1 secretion from L cells and alpha cells. Nat Med 17(11):1481-9. [PubMed: 22037645]  [MGI Ref ID J:179825]

Eriksson U; Kurrer MO; Schmitz N; Marsch SC; Fontana A; Eugster HP; Kopf M. 2003. Interleukin-6-deficient mice resist development of autoimmune myocarditis associated with impaired upregulation of complement C3. Circulation 107(2):320-5. [PubMed: 12538435]  [MGI Ref ID J:103083]

Ernst M; Najdovska M; Grail D; Lundgren-May T; Buchert M; Tye H; Matthews VB; Armes J; Bhathal PS; Hughes NR; Marcusson EG; Karras JG; Na S; Sedgwick JD; Hertzog PJ; Jenkins BJ. 2008. STAT3 and STAT1 mediate IL-11-dependent and inflammation-associated gastric tumorigenesis in gp130 receptor mutant mice. J Clin Invest 118(5):1727-38. [PubMed: 18431520]  [MGI Ref ID J:135184]

Eto D; Lao C; DiToro D; Barnett B; Escobar TC; Kageyama R; Yusuf I; Crotty S. 2011. IL-21 and IL-6 are critical for different aspects of B cell immunity and redundantly induce optimal follicular helper CD4 T cell (Tfh) differentiation. PLoS One 6(3):e17739. [PubMed: 21423809]  [MGI Ref ID J:171690]

Eugster HP; Frei K; Winkler F; Koedel U; Pfister W; Lassmann H; Fontana A. 2001. Superantigen overcomes resistance of IL-6-deficient mice towards MOG-induced EAE by a TNFR1 controlled pathway. Eur J Immunol 31(8):2302-12. [PubMed: 11477542]  [MGI Ref ID J:71157]

Evans R; Shultz LD; Dranoff G; Fuller JA; Kamdar SJ. 1998. CSF-1 regulation of Il6 gene expression by murine macrophages: a pivotal role for GM-CSF. J Leukoc Biol 64(6):810-6. [PubMed: 9850165]  [MGI Ref ID J:51325]

Evans SE; Scott BL; Clement CG; Larson DT; Kontoyiannis D; Lewis RE; Lasala PR; Pawlik J; Peterson JW; Chopra AK; Klimpel G; Bowden G; Hook M; Xu Y; Tuvim MJ; Dickey BF. 2010. Stimulated innate resistance of lung epithelium protects mice broadly against bacteria and fungi. Am J Respir Cell Mol Biol 42(1):40-50. [PubMed: 19329554]  [MGI Ref ID J:168453]

Faldt J; Wernstedt I; Fitzgerald SM; Wallenius K; Bergstrom G; Jansson JO. 2004. Reduced exercise endurance in interleukin-6-deficient mice. Endocrinology 145(6):2680-6. [PubMed: 14988384]  [MGI Ref ID J:105633]

Fang C; Zhang X; Miwa T; Song WC. 2009. Complement promotes the development of inflammatory T-helper 17 cells through synergistic interaction with Toll-like receptor signaling and interleukin-6 production. Blood 114(5):1005-15. [PubMed: 19491392]  [MGI Ref ID J:151430]

Fehervari Z; Sakaguchi S. 2004. Control of Foxp3+ CD25+CD4+ regulatory cell activation and function by dendritic cells. Int Immunol 16(12):1769-80. [PubMed: 15520045]  [MGI Ref ID J:94004]

Fenton RR; Molesworth-Kenyon S; Oakes JE; Lausch RN. 2002. Linkage of IL-6 with neutrophil chemoattractant expression in virus-induced ocular inflammation. Invest Ophthalmol Vis Sci 43(3):737-43. [PubMed: 11867592]  [MGI Ref ID J:119135]

Fielding CA; Jones GW; McLoughlin RM; McLeod L; Hammond VJ; Uceda J; Williams AS; Lambie M; Foster TL; Liao CT; Rice CM; Greenhill CJ; Colmont CS; Hams E; Coles B; Kift-Morgan A; Newton Z; Craig KJ; Williams JD; Williams GT; Davies SJ; Humphreys IR; O'Donnell VB; Taylor PR; Jenkins BJ; Topley N; Jones SA. 2014. Interleukin-6 signaling drives fibrosis in unresolved inflammation. Immunity 40(1):40-50. [PubMed: 24412616]  [MGI Ref ID J:209391]

Fielding CA; McLoughlin RM; McLeod L; Colmont CS; Najdovska M; Grail D; Ernst M; Jones SA; Topley N; Jenkins BJ. 2008. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3. J Immunol 181(3):2189-95. [PubMed: 18641358]  [MGI Ref ID J:139226]

Fooksman DR; Nussenzweig MC; Dustin ML. 2014. Myeloid cells limit production of antibody-secreting cells after immunization in the lymph node. J Immunol 192(3):1004-12. [PubMed: 24376270]  [MGI Ref ID J:207304]

Fritsche L; Hoene M; Lehmann R; Ellingsgaard H; Hennige AM; Pohl AK; Haring HU; Schleicher ED; Weigert C. 2010. IL-6 deficiency in mice neither impairs induction of metabolic genes in the liver nor affects blood glucose levels during fasting and moderately intense exercise. Diabetologia 53(8):1732-42. [PubMed: 20411234]  [MGI Ref ID J:162167]

Fuchs M; Hilfiker A; Kaminski K; Hilfiker-Kleiner D; Guener Z; Klein G; Podewski E; Schieffer B; Rose-John S; Drexler H. 2003. Role of interleukin-6 for LV remodeling and survival after experimental myocardial infarction. FASEB J 17(14):2118-20. [PubMed: 12958147]  [MGI Ref ID J:118479]

Fujimaki H; Kurokawa Y; Yamamoto S; Satoh M. 2006. Distinct requirements for interleukin-6 in airway inflammation induced by diesel exhaust in mice. Immunopharmacol Immunotoxicol 28(4):703-14. [PubMed: 17190745]  [MGI Ref ID J:136469]

Gabay C; Gigley J; Sipe J; Arend WP; Fantuzzi G. 2001. Production of IL-1 receptor antagonist by hepatocytes is regulated as an acute-phase protein in vivo. Eur J Immunol 31(2):490-9. [PubMed: 11180114]  [MGI Ref ID J:134201]

Gallucci RM; Lee EG; Tomasek JJ. 2006. IL-6 modulates alpha-smooth muscle actin expression in dermal fibroblasts from IL-6-deficient mice. J Invest Dermatol 126(3):561-8. [PubMed: 16397521]  [MGI Ref ID J:106773]

Gallucci RM; Simeonova PP; Matheson JM; Kommineni C; Guriel JL; Sugawara T; Luster MI. 2000. Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice FASEB J 14(15):2525-31. [PubMed: 11099471]  [MGI Ref ID J:66089]

Ganeshan K; Bryce PJ. 2012. Regulatory T cells enhance mast cell production of IL-6 via surface-bound TGF-beta. J Immunol 188(2):594-603. [PubMed: 22156492]  [MGI Ref ID J:180880]

Ganeshan K; Johnston LK; Bryce PJ. 2013. TGF-beta1 limits the onset of innate lung inflammation by promoting mast cell-derived IL-6. J Immunol 190(11):5731-8. [PubMed: 23630359]  [MGI Ref ID J:204772]

Gao S; Li A; Liu F; Chen F; Williams M; Zhang C; Kelley Z; Wu CL; Luo R; Xiao H. 2013. NCOA5 haploinsufficiency results in glucose intolerance and subsequent hepatocellular carcinoma. Cancer Cell 24(6):725-37. [PubMed: 24332041]  [MGI Ref ID J:207622]

Gao W; Pereira MA. 2002. Interleukin-6 is required for parasite specific response and host resistance to Trypanosoma cruzi. Int J Parasitol 32(2):167-70. [PubMed: 11812493]  [MGI Ref ID J:106201]

Gardenghi S; Renaud TM; Meloni A; Casu C; Crielaard BJ; Bystrom LM; Greenberg-Kushnir N; Sasu BJ; Cooke KS; Rivella S. 2014. Distinct roles for hepcidin and interleukin-6 in the recovery from anemia in mice injected with heat-killed Brucella abortus. Blood 123(8):1137-45. [PubMed: 24357729]  [MGI Ref ID J:208698]

Geisel J; Kahl F; Muller M; Wagner H; Kirschning CJ; Autenrieth IB; Frick JS. 2007. IL-6 and maturation govern TLR2 and TLR4 induced TLR agonist tolerance and cross-tolerance in dendritic cells. J Immunol 179(9):5811-8. [PubMed: 17947654]  [MGI Ref ID J:153008]

Gilbert MR; Wagner NJ; Jones SZ; Wisz AB; Roques JR; Krum KN; Lee SR; Nickeleit V; Hulbert C; Thomas JW; Gauld SB; Vilen BJ. 2012. Autoreactive preplasma cells break tolerance in the absence of regulation by dendritic cells and macrophages. J Immunol 189(2):711-20. [PubMed: 22675201]  [MGI Ref ID J:189561]

Giralt M; Ramos R; Quintana A; Ferrer B; Erta M; Castro-Freire M; Comes G; Sanz E; Unzeta M; Pifarre P; Garcia A; Campbell IL; Hidalgo J. 2013. Induction of atypical EAE mediated by transgenic production of IL-6 in astrocytes in the absence of systemic IL-6. Glia 61(4):587-600. [PubMed: 23322593]  [MGI Ref ID J:193408]

Goodwill MH; Lawrence DA; Seegal RF. 2007. Polychlorinated biphenyls induce proinflammatory cytokine release and dopaminergic dysfunction: protection in interleukin-6 knockout mice. J Neuroimmunol 183(1-2):125-32. [PubMed: 17229471]  [MGI Ref ID J:124502]

Gowen BB; Hoopes JD; Wong MH; Jung KH; Isakson KC; Alexopoulou L; Flavell RA; Sidwell RW. 2006. TLR3 deletion limits mortality and disease severity due to Phlebovirus infection. J Immunol 177(9):6301-7. [PubMed: 17056560]  [MGI Ref ID J:140514]

Greenhill CJ; Rose-John S; Lissilaa R; Ferlin W; Ernst M; Hertzog PJ; Mansell A; Jenkins BJ. 2011. IL-6 trans-signaling modulates TLR4-dependent inflammatory responses via STAT3. J Immunol 186(2):1199-208. [PubMed: 21148800]  [MGI Ref ID J:168781]

Gregory AD; Capoccia BJ; Woloszynek JR; Link DC. 2010. Systemic levels of G-CSF and interleukin-6 determine the angiogenic potential of bone marrow resident monocytes. J Leukoc Biol 88(1):123-31. [PubMed: 20354107]  [MGI Ref ID J:162446]

Grivennikov S; Karin E; Terzic J; Mucida D; Yu GY; Vallabhapurapu S; Scheller J; Rose-John S; Cheroutre H; Eckmann L; Karin M. 2009. IL-6 and stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell 15(2):103-13. [PubMed: 19185845]  [MGI Ref ID J:144813]

Guma M; Stepniak D; Shaked H; Spehlmann ME; Shenouda S; Cheroutre H; Vicente-Suarez I; Eckmann L; Kagnoff MF; Karin M. 2011. Constitutive intestinal NF-kappaB does not trigger destructive inflammation unless accompanied by MAPK activation. J Exp Med 208(9):1889-900. [PubMed: 21825016]  [MGI Ref ID J:177595]

Gutierrez T; Halcomb KE; Coughran AJ; Li QZ; Satterthwaite AB. 2010. Separate checkpoints regulate splenic plasma cell accumulation and IgG autoantibody production in Lyn-deficient mice. Eur J Immunol 40(7):1897-905. [PubMed: 20394076]  [MGI Ref ID J:165938]

Gutierrez T; Mayeux JM; Ortega SB; Karandikar NJ; Li QZ; Rakheja D; Zhou XJ; Satterthwaite AB. 2013. IL-21 promotes the production of anti-DNA IgG but is dispensable for kidney damage in lyn(-/-) mice. Eur J Immunol 43(2):382-93. [PubMed: 23169140]  [MGI Ref ID J:192815]

Hadziahmetovic M; Song Y; Ponnuru P; Iacovelli J; Hunter A; Haddad N; Beard J; Connor JR; Vaulont S; Dunaief JL. 2011. Age-dependent retinal iron accumulation and degeneration in hepcidin knockout mice. Invest Ophthalmol Vis Sci 52(1):109-18. [PubMed: 20811044]  [MGI Ref ID J:171564]

Hadziahmetovic M; Song Y; Wolkow N; Iacovelli J; Kautz L; Roth MP; Dunaief JL. 2011. Bmp6 regulates retinal iron homeostasis and has altered expression in age-related macular degeneration. Am J Pathol 179(1):335-48. [PubMed: 21703414]  [MGI Ref ID J:174000]

Hall JA; Bouladoux N; Sun CM; Wohlfert EA; Blank RB; Zhu Q; Grigg ME; Berzofsky JA; Belkaid Y. 2008. Commensal DNA limits regulatory T cell conversion and is a natural adjuvant of intestinal immune responses. Immunity 29(4):637-49. [PubMed: 18835196]  [MGI Ref ID J:141440]

Hams E; Colmont CS; Dioszeghy V; Hammond VJ; Fielding CA; Williams AS; Tanaka M; Miyajima A; Taylor PR; Topley N; Jones SA. 2008. Oncostatin M receptor-beta signaling limits monocytic cell recruitment in acute inflammation. J Immunol 181(3):2174-80. [PubMed: 18641356]  [MGI Ref ID J:139227]

Harker JA; Lewis GM; Mack L; Zuniga EI. 2011. Late interleukin-6 escalates T follicular helper cell responses and controls a chronic viral infection. Science 334(6057):825-9. [PubMed: 21960530]  [MGI Ref ID J:177869]

Hata H; Sakaguchi N; Yoshitomi H; Iwakura Y; Sekikawa K; Azuma Y; Kanai C; Moriizumi E; Nomura T; Nakamura T; Sakaguchi S. 2004. Distinct contribution of IL-6, TNF-alpha, IL-1, and IL-10 to T cell-mediated spontaneous autoimmune arthritis in mice. J Clin Invest 114(4):582-8. [PubMed: 15314695]  [MGI Ref ID J:92002]

Hayashi T; Cottam HB; Chan M; Jin G; Tawatao RI; Crain B; Ronacher L; Messer K; Carson DA; Corr M. 2008. Mast cell-dependent anorexia and hypothermia induced by mucosal activation of Toll-like receptor 7. Am J Physiol Regul Integr Comp Physiol 295(1):R123-32. [PubMed: 18480244]  [MGI Ref ID J:148644]

Heidegger S; Kirchner SK; Stephan N; Bohn B; Suhartha N; Hotz C; Anz D; Sandholzer N; Stecher B; Russmann H; Endres S; Bourquin C. 2013. TLR activation excludes circulating naive CD8+ T cells from gut-associated lymphoid organs in mice. J Immunol 190(10):5313-20. [PubMed: 23589622]  [MGI Ref ID J:202547]

Hilbert DM; Kopf M; Mock BA; Kohler G; Rudikoff S. 1995. Interleukin 6 is essential for in vivo development of B lineage neoplasms. J Exp Med 182(1):243-8. [PubMed: 7790819]  [MGI Ref ID J:26249]

Hill JA; Hall JA; Sun CM; Cai Q; Ghyselinck N; Chambon P; Belkaid Y; Mathis D; Benoist C. 2008. Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi Cells. Immunity 29(5):758-70. [PubMed: 19006694]  [MGI Ref ID J:142396]

Hirota K; Hashimoto M; Yoshitomi H; Tanaka S; Nomura T; Yamaguchi T; Iwakura Y; Sakaguchi N; Sakaguchi S. 2007. T cell self-reactivity forms a cytokine milieu for spontaneous development of IL-17+ Th cells that cause autoimmune arthritis. J Exp Med 204(1):41-7. [PubMed: 17227914]  [MGI Ref ID J:125290]

Hodes GE; Pfau ML; Leboeuf M; Golden SA; Christoffel DJ; Bregman D; Rebusi N; Heshmati M; Aleyasin H; Warren BL; Lebonte B; Horn S; Lapidus KA; Stelzhammer V; Wong EH; Bahn S; Krishnan V; Bolanos-Guzman CA; Murrough JW; Merad M; Russo SJ. 2014. Individual differences in the peripheral immune system promote resilience versus susceptibility to social stress. Proc Natl Acad Sci U S A 111(45):16136-41. [PubMed: 25331895]  [MGI Ref ID J:216663]

Hoene M; Runge H; Haring HU; Schleicher ED; Weigert C. 2013. Interleukin-6 promotes myogenic differentiation of mouse skeletal muscle cells: role of the STAT3 pathway. Am J Physiol Cell Physiol 304(2):C128-36. [PubMed: 23114963]  [MGI Ref ID J:194699]

Hoetzenecker W; Echtenacher B; Guenova E; Hoetzenecker K; Woelbing F; Bruck J; Teske A; Valtcheva N; Fuchs K; Kneilling M; Park JH; Kim KH; Kim KW; Hoffmann P; Krenn C; Hai T; Ghoreschi K; Biedermann T; Rocken M. 2012. ROS-induced ATF3 causes susceptibility to secondary infections during sepsis-associated immunosuppression. Nat Med 18(1):128-34. [PubMed: 22179317]  [MGI Ref ID J:180781]

Hofstetter HH; Sewell DL; Liu F; Sandor M; Forsthuber T; Lehmann PV; Fabry Z. 2003. Autoreactive T cells promote post-traumatic healing in the central nervous system. J Neuroimmunol 134(1-2):25-34. [PubMed: 12507769]  [MGI Ref ID J:119263]

Hoge J; Yan I; Janner N; Schumacher V; Chalaris A; Steinmetz OM; Engel DR; Scheller J; Rose-John S; Mittrucker HW. 2013. IL-6 Controls the Innate Immune Response against Listeria monocytogenes via Classical IL-6 Signaling. J Immunol 190(2):703-11. [PubMed: 23241882]  [MGI Ref ID J:191190]

Hong F; Jaruga B; Kim WH; Radaeva S; El-Assal ON; Tian Z; Nguyen VA; Gao B. 2002. Opposing roles of STAT1 and STAT3 in T cell-mediated hepatitis: regulation by SOCS. J Clin Invest 110(10):1503-13. [PubMed: 12438448]  [MGI Ref ID J:80183]

Hong F; Kim WH; Tian Z; Jaruga B; Ishac E; Shen X; Gao B. 2002. Elevated interleukin-6 during ethanol consumption acts as a potential endogenous protective cytokine against ethanol-induced apoptosis in the liver: involvement of induction of Bcl-2 and Bcl-x(L) proteins. Oncogene 21(1):32-43. [PubMed: 11791174]  [MGI Ref ID J:127042]

Hou W; Jin YH; Kang HS; Kim BS. 2014. Interleukin-6 (IL-6) and IL-17 synergistically promote viral persistence by inhibiting cellular apoptosis and cytotoxic T cell function. J Virol 88(15):8479-89. [PubMed: 24829345]  [MGI Ref ID J:214388]

Hou W; Kang HS; Kim BS. 2009. Th17 cells enhance viral persistence and inhibit T cell cytotoxicity in a model of chronic virus infection. J Exp Med 206(2):313-28. [PubMed: 19204109]  [MGI Ref ID J:146452]

Howlett M; Judd LM; Jenkins B; La Gruta NL; Grail D; Ernst M; Giraud AS. 2005. Differential regulation of gastric tumor growth by cytokines that signal exclusively through the coreceptor gp130. Gastroenterology 129(3):1005-18. [PubMed: 16143138]  [MGI Ref ID J:103565]

Hruz P; Zinkernagel AS; Jenikova G; Botwin GJ; Hugot JP; Karin M; Nizet V; Eckmann L. 2009. NOD2 contributes to cutaneous defense against Staphylococcus aureus through alpha-toxin-dependent innate immune activation. Proc Natl Acad Sci U S A 106(31):12873-8. [PubMed: 19541630]  [MGI Ref ID J:151511]

Hryniewicz A; Bialuk I; Kaminski KA; Winnicka MM. 2007. Impairment of recognition memory in interleukin-6 knock-out mice. Eur J Pharmacol 577(1-3):219-20. [PubMed: 17920057]  [MGI Ref ID J:139627]

Huang G; Wang Y; Vogel P; Kanneganti TD; Otsu K; Chi H. 2012. Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat Immunol 13(2):152-61. [PubMed: 22231518]  [MGI Ref ID J:181211]

Hume EB; Cole N; Garthwaite LL; Khan S; Willcox MD. 2006. A protective role for IL-6 in staphylococcal microbial keratitis. Invest Ophthalmol Vis Sci 47(11):4926-30. [PubMed: 17065508]  [MGI Ref ID J:123089]

Huszarik K; Wright B; Keller C; Nikoopour E; Krougly O; Lee-Chan E; Qin HY; Cameron MJ; Gurr WK; Hill DJ; Sherwin RS; Kelvin DJ; Singh B. 2010. Adjuvant immunotherapy increases beta cell regenerative factor Reg2 in the pancreas of diabetic mice. J Immunol 185(9):5120-9. [PubMed: 20876350]  [MGI Ref ID J:165194]

Ikeda S; Saijo S; Murayama MA; Shimizu K; Akitsu A; Iwakura Y. 2014. Excess IL-1 signaling enhances the development of Th17 cells by downregulating TGF-beta-induced Foxp3 expression. J Immunol 192(4):1449-58. [PubMed: 24431229]  [MGI Ref ID J:209377]

Imai Y; Kuba K; Neely GG; Yaghubian-Malhami R; Perkmann T; van Loo G; Ermolaeva M; Veldhuizen R; Leung YH; Wang H; Liu H; Sun Y; Pasparakis M; Kopf M; Mech C; Bavari S; Peiris JS; Slutsky AS; Akira S; Hultqvist M; Holmdahl R; Nicholls J; Jiang C; Binder CJ; Penninger JM. 2008. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell 133(2):235-49. [PubMed: 18423196]  [MGI Ref ID J:145306]

Iniguez M; Berasain C; Martinez-Anso E; Bustos M; Fortes P; Pennica D; Avila MA; Prieto J. 2006. Cardiotrophin-1 defends the liver against ischemia-reperfusion injury and mediates the protective effect of ischemic preconditioning. J Exp Med 203(13):2809-15. [PubMed: 17178916]  [MGI Ref ID J:124595]

Inoue H; Ogawa W; Asakawa A; Okamoto Y; Nishizawa A; Matsumoto M; Teshigawara K; Matsuki Y; Watanabe E; Hiramatsu R; Notohara K; Katayose K; Okamura H; Kahn CR; Noda T; Takeda K; Akira S; Inui A; Kasuga M. 2006. Role of hepatic STAT3 in brain-insulin action on hepatic glucose production. Cell Metab 3(4):267-75. [PubMed: 16581004]  [MGI Ref ID J:109359]

Ivanov II; McKenzie BS; Zhou L; Tadokoro CE; Lepelley A; Lafaille JJ; Cua DJ; Littman DR. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126(6):1121-33. [PubMed: 16990136]  [MGI Ref ID J:115922]

Izumi-Nagai K; Nagai N; Ozawa Y; Mihara M; Ohsugi Y; Kurihara T; Koto T; Satofuka S; Inoue M; Tsubota K; Okano H; Oike Y; Ishida S. 2007. Interleukin-6 receptor-mediated activation of signal transducer and activator of transcription-3 (STAT3) promotes choroidal neovascularization. Am J Pathol 170(6):2149-58. [PubMed: 17525280]  [MGI Ref ID J:122177]

Jang SY; Shin YK; Lee HY; Park JY; Suh DJ; Kim JK; Bae YS; Park HT. 2012. Local production of serum amyloid a is implicated in the induction of macrophage chemoattractants in Schwann cells during wallerian degeneration of peripheral nerves. Glia 60(10):1619-28. [PubMed: 22777957]  [MGI Ref ID J:186481]

Jenkins BJ; Roberts AW; Greenhill CJ; Najdovska M; Lundgren-May T; Robb L; Grail D; Ernst M. 2007. Pathologic consequences of STAT3 hyperactivation by IL-6 and IL-11 during hematopoiesis and lymphopoiesis. Blood 109(6):2380-8. [PubMed: 17082315]  [MGI Ref ID J:143670]

Ji H; Pettit A; Ohmura K; Ortiz-Lopez A; Duchatelle V; Degott C; Gravallese E; Mathis D; Benoist C. 2002. Critical roles for interleukin 1 and tumor necrosis factor alpha in antibody-induced arthritis. J Exp Med 196(1):77-85. [PubMed: 12093872]  [MGI Ref ID J:132920]

Ji R; Tian S; Lu HJ; Lu Q; Zheng Y; Wang X; Ding J; Li Q; Lu Q. 2013. TAM receptors affect adult brain neurogenesis by negative regulation of microglial cell activation. J Immunol 191(12):6165-77. [PubMed: 24244024]  [MGI Ref ID J:207107]

Jin X; Zimmers TA; Zhang Z; Pierce RH; Koniaris LG. 2010. Interleukin-6 is an important in vivo inhibitor of intestinal epithelial cell death in mice. Gut 59(2):186-96. [PubMed: 19074180]  [MGI Ref ID J:194147]

Joetham A; Okamoto M; Takeda K; Schedel M; Ohnishi H; Dakhama A; Gelfand EW. 2011. CD8 regulates T regulatory cell production of IL-6 and maintains their suppressive phenotype in allergic lung disease. J Immunol 186(1):113-20. [PubMed: 21115736]  [MGI Ref ID J:168721]

Johnston RA; Schwartzman IN; Flynt L; Shore SA. 2005. Role of interleukin-6 in murine airway responses to ozone. Am J Physiol Lung Cell Mol Physiol 288(2):L390-7. [PubMed: 15516495]  [MGI Ref ID J:104765]

Jolicoeur P; Hu C; Mak TW; Martinou JC; Kay DG. 2003. Protection against murine leukemia virus-induced spongiform myeloencephalopathy in mice overexpressing Bcl-2 but not in mice deficient for interleukin-6, inducible nitric oxide synthetase, ICE, Fas, Fas ligand, or TNF-R1 genes. J Virol 77(24):13161-70. [PubMed: 14645573]  [MGI Ref ID J:86761]

Jones GW; McLoughlin RM; Hammond VJ; Parker CR; Williams JD; Malhotra R; Scheller J; Williams AS; Rose-John S; Topley N; Jones SA. 2010. Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J Immunol 184(4):2130-9. [PubMed: 20083667]  [MGI Ref ID J:159479]

Jones TG; Finkelman FD; Austen KF; Gurish MF. 2010. T regulatory cells control antigen-induced recruitment of mast cell progenitors to the lungs of C57BL/6 mice. J Immunol 185(3):1804-11. [PubMed: 20601599]  [MGI Ref ID J:162451]

Judd LM; Ulaganathan M; Howlett M; Giraud AS. 2009. Cytokine signalling by gp130 regulates gastric mucosal healing after ulceration and, indirectly, antral tumour progression. J Pathol 217(4):552-62. [PubMed: 19097069]  [MGI Ref ID J:145736]

Kagari T; Doi H; Shimozato T. 2002. The importance of IL-1 beta and TNF-alpha, and the noninvolvement of IL-6, in the development of monoclonal antibody-induced arthritis. J Immunol 169(3):1459-66. [PubMed: 12133972]  [MGI Ref ID J:120707]

Kagiwada K; Chida D; Sakatani T; Asano M; Nambu A; Kakuta S; Iwakura Y. 2004. Interleukin (IL)-6, but not IL-1, induction in the brain downstream of cyclooxygenase-2 is essential for the induction of febrile response against peripheral IL-1alpha. Endocrinology 145(11):5044-8. [PubMed: 15271886]  [MGI Ref ID J:105613]

Kammertoens T; Qin Z; Briesemeister D; Bendelac A; Blankenstein T. 2012. B-cells and IL-4 promote methylcholanthrene-induced carcinogenesis but there is no evidence for a role of T/NKT-cells and their effector molecules (Fas-ligand, TNF-alpha, perforin). Int J Cancer 131(7):1499-508. [PubMed: 22212899]  [MGI Ref ID J:186111]

Kansara M; Leong HS; Lin DM; Popkiss S; Pang P; Garsed DW; Walkley CR; Cullinane C; Ellul J; Haynes NM; Hicks R; Kuijjer ML; Cleton-Jansen AM; Hinds PW; Smyth MJ; Thomas DM. 2013. Immune response to RB1-regulated senescence limits radiation-induced osteosarcoma formation. J Clin Invest 123(12):5351-60. [PubMed: 24231354]  [MGI Ref ID J:207626]

Karnowski A; Chevrier S; Belz GT; Mount A; Emslie D; D'Costa K; Tarlinton DM; Kallies A; Corcoran LM. 2012. B and T cells collaborate in antiviral responses via IL-6, IL-21, and transcriptional activator and coactivator, Oct2 and OBF-1. J Exp Med 209(11):2049-64. [PubMed: 23045607]  [MGI Ref ID J:190912]

Kasahara DI; Kim HY; Mathews JA; Verbout NG; Williams AS; Wurmbrand AP; Ninin FM; Neto FL; Benedito LA; Hug C; Umetsu DT; Shore SA. 2014. Pivotal role of IL-6 in the hyperinflammatory responses to subacute ozone in adiponectin-deficient mice. Am J Physiol Lung Cell Mol Physiol 306(6):L508-20. [PubMed: 24381131]  [MGI Ref ID J:210897]

Kastenmuller W; Torabi-Parizi P; Subramanian N; Lammermann T; Germain RN. 2012. A spatially-organized multicellular innate immune response in lymph nodes limits systemic pathogen spread. Cell 150(6):1235-48. [PubMed: 22980983]  [MGI Ref ID J:187962]

Kawagoe T; Takeuchi O; Takabatake Y; Kato H; Isaka Y; Tsujimura T; Akira S. 2009. TANK is a negative regulator of Toll-like receptor signaling and is critical for the prevention of autoimmune nephritis. Nat Immunol 10(9):965-72. [PubMed: 19668221]  [MGI Ref ID J:151757]

Kawane K; Tanaka H; Kitahara Y; Shimaoka S; Nagata S. 2010. Cytokine-dependent but acquired immunity-independent arthritis caused by DNA escaped from degradation. Proc Natl Acad Sci U S A 107(45):19432-7. [PubMed: 20974942]  [MGI Ref ID J:167378]

Keller C; Keller P; Giralt M; Hidalgo J; Pedersen BK. 2004. Exercise normalises overexpression of TNF-alpha in knockout mice. Biochem Biophys Res Commun 321(1):179-82. [PubMed: 15358232]  [MGI Ref ID J:91303]

Kellermann SA; McEvoy LM. 2001. The Peyer's patch microenvironment suppresses T cell responses to chemokines and other stimuli. J Immunol 167(2):682-90. [PubMed: 11441071]  [MGI Ref ID J:120507]

Kelly M; Keller C; Avilucea PR; Keller P; Luo Z; Xiang X; Giralt M; Hidalgo J; Saha AK; Pedersen BK; Ruderman NB. 2004. AMPK activity is diminished in tissues of IL-6 knockout mice: the effect of exercise. Biochem Biophys Res Commun 320(2):449-54. [PubMed: 15219849]  [MGI Ref ID J:90952]

Kennedy CL; Najdovska M; Jones GW; McLeod L; Hughes NR; Allison C; Huey Ooi C; Tan P; Ferrero RL; Jones SA; Dev A; Sievert W; Bhathal PS; Jenkins BJ. 2011. The molecular pathogenesis of STAT3-driven gastric tumourigenesis in mice is independent of IL-17. J Pathol 225(2):255-64. [PubMed: 21710691]  [MGI Ref ID J:175909]

Khiong K; Murakami M; Kitabayashi C; Ueda N; Sawa S; Sakamoto A; Kotzin BL; Rozzo SJ; Ishihara K; Verella-Garcia M; Kappler J; Marrack P; Hirano T. 2007. Homeostatically proliferating CD4 T cells are involved in the pathogenesis of an Omenn syndrome murine model. J Clin Invest 117(5):1270-81. [PubMed: 17476359]  [MGI Ref ID J:122142]

Kida H; Yoshida M; Hoshino S; Inoue K; Yano Y; Yanagita M; Kumagai T; Osaki T; Tachibana I; Saeki Y; Kawase I. 2005. Protective effect of IL-6 on alveolar epithelial cell death induced by hydrogen peroxide. Am J Physiol Lung Cell Mol Physiol 288(2):L342-9. [PubMed: 15475383]  [MGI Ref ID J:115453]

Kielar ML; John R; Bennett M; Richardson JA; Shelton JM; Chen L; Jeyarajah DR; Zhou XJ; Zhou H; Chiquett B; Nagami GT; Lu CY. 2005. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16(11):3315-25. [PubMed: 16192425]  [MGI Ref ID J:116849]

Kilmon MA; Wagner NJ; Garland AL; Lin L; Aviszus K; Wysocki LJ; Vilen BJ. 2007. Macrophages prevent the differentiation of autoreactive B cells by secreting CD40 ligand and interleukin-6. Blood 110(5):1595-602. [PubMed: 17712049]  [MGI Ref ID J:145511]

Kim S; Takahashi H; Lin WW; Descargues P; Grivennikov S; Kim Y; Luo JL; Karin M. 2009. Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis. Nature 457(7225):102-6. [PubMed: 19122641]  [MGI Ref ID J:143870]

Kim SJ; Zou YR; Goldstein J; Reizis B; Diamond B. 2011. Tolerogenic function of Blimp-1 in dendritic cells. J Exp Med 208(11):2193-9. [PubMed: 21948081]  [MGI Ref ID J:178876]

Kim SV; Xiang WV; Kwak C; Yang Y; Lin XW; Ota M; Sarpel U; Rifkin DB; Xu R; Littman DR. 2013. GPR15-mediated homing controls immune homeostasis in the large intestine mucosa. Science 340(6139):1456-9. [PubMed: 23661644]  [MGI Ref ID J:199126]

Kinoshita H; Hirata Y; Nakagawa H; Sakamoto K; Hayakawa Y; Takahashi R; Nakata W; Sakitani K; Serizawa T; Hikiba Y; Akanuma M; Shibata W; Maeda S; Koike K. 2013. Interleukin-6 mediates epithelial-stromal interactions and promotes gastric tumorigenesis. PLoS One 8(4):e60914. [PubMed: 23593346]  [MGI Ref ID J:200580]

Kitaba S; Murota H; Terao M; Azukizawa H; Terabe F; Shima Y; Fujimoto M; Tanaka T; Naka T; Kishimoto T; Katayama I. 2012. Blockade of interleukin-6 receptor alleviates disease in mouse model of scleroderma. Am J Pathol 180(1):165-76. [PubMed: 22062222]  [MGI Ref ID J:180181]

Kitamura K; Nakamoto Y; Kaneko S; Mukaida N. 2004. Pivotal roles of interleukin-6 in transmural inflammation in murine T cell transfer colitis. J Leukoc Biol 76(6):1111-7. [PubMed: 15339938]  [MGI Ref ID J:94173]

Knight B; Yeoh GC; Husk KL; Ly T; Abraham LJ; Yu C; Rhim JA; Fausto N. 2000. Impaired preneoplastic changes and liver tumor formation in tumor necrosis factor receptor type 1 knockout mice J Exp Med 192(12):1809-18. [PubMed: 11120777]  [MGI Ref ID J:66448]

Knudsen JG; Murholm M; Carey AL; Bienso RS; Basse AL; Allen TL; Hidalgo J; Kingwell BA; Febbraio MA; Hansen JB; Pilegaard H. 2014. Role of IL-6 in exercise training- and cold-induced UCP1 expression in subcutaneous white adipose tissue. PLoS One 9(1):e84910. [PubMed: 24416310]  [MGI Ref ID J:212205]

Kopf M; Herren S; Wiles MV; Pepys MB; Kosco-Vilbois MH. 1998. Interleukin 6 influences germinal center development and antibody production via a contribution of C3 complement component. J Exp Med 188(10):1895-906. [PubMed: 9815267]  [MGI Ref ID J:79296]

Korn T; Bettelli E; Gao W; Awasthi A; Jager A; Strom TB; Oukka M; Kuchroo VK. 2007. IL-21 initiates an alternative pathway to induce proinflammatory T(H)17 cells. Nature 448(7152):484-7. [PubMed: 17581588]  [MGI Ref ID J:123352]

Kottke T; Sanchez-Perez L; Diaz RM; Thompson J; Chong H; Harrington K; Calderwood SK; Pulido J; Georgopoulos N; Selby P; Melcher A; Vile R. 2007. Induction of hsp70-mediated Th17 autoimmunity can be exploited as immunotherapy for metastatic prostate cancer. Cancer Res 67(24):11970-9. [PubMed: 18089828]  [MGI Ref ID J:129230]

Kozak W; Wrotek S; Kozak A. 2006. Pyrogenicity of CpG-DNA in mice: role of interleukin-6, cyclooxygenases, and nuclear factor-kappaB. Am J Physiol Regul Integr Comp Physiol 290(4):R871-80. [PubMed: 16293680]  [MGI Ref ID J:115760]

Krishnamoorthy N; Oriss TB; Paglia M; Fei M; Yarlagadda M; Vanhaesebroeck B; Ray A; Ray P. 2008. Activation of c-Kit in dendritic cells regulates T helper cell differentiation and allergic asthma. Nat Med 14(5):565-73. [PubMed: 18454155]  [MGI Ref ID J:136704]

Kryczek I; Wei S; Vatan L; Escara-Wilke J; Szeliga W; Keller ET; Zou W. 2007. Cutting edge: opposite effects of IL-1 and IL-2 on the regulation of IL-17+ T cell pool IL-1 subverts IL-2-mediated suppression. J Immunol 179(3):1423-6. [PubMed: 17641006]  [MGI Ref ID J:149956]

Kurihara N; Hiruma Y; Yamana K; Michou L; Rousseau C; Morissette J; Galson DL; Teramachi J; Zhou H; Dempster DW; Windle JJ; Brown JP; Roodman GD. 2011. Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62(P392L) mutation to Paget's disease. Cell Metab 13(1):23-34. [PubMed: 21195346]  [MGI Ref ID J:169480]

Kurtz SL; Foreman O; Bosio CM; Anver MR; Elkins KL. 2013. Interleukin-6 Is Essential for Primary Resistance to Francisella tularensis Live Vaccine Strain Infection. Infect Immun 81(2):585-97. [PubMed: 23230288]  [MGI Ref ID J:192548]

Ladel CH; Blum C; Dreher A; Reifenberg K; Kopf M; Kaufmann SH. 1997. Lethal tuberculosis in interleukin-6-deficient mutant mice. Infect Immun 65(11):4843-9. [PubMed: 9353074]  [MGI Ref ID J:43807]

Lager S; Asterholm IW; Schele E; Jansson N; Nilsson S; Jansson JO; Lonn M; Holmang A. 2011. Perinatal lack of maternal IL-6 promotes increased adiposity during adulthood in mice. Endocrinology 152(4):1336-46. [PubMed: 21285312]  [MGI Ref ID J:173869]

Lai NC; Gao MH; Tang E; Tang R; Guo T; Dalton ND; Deng A; Tang T. 2012. Pressure overload-induced cardiac remodeling and dysfunction in the absence of interleukin 6 in mice. Lab Invest 92(11):1518-26. [PubMed: 22825686]  [MGI Ref ID J:189596]

Laing GD; Clissa PB; Theakston RD; Moura-da-Silva AM; Taylor MJ. 2003. Inflammatory pathogenesis of snake venom metalloproteinase-induced skin necrosis. Eur J Immunol 33(12):3458-63. [PubMed: 14635056]  [MGI Ref ID J:87138]

Lauder SN; Jones E; Smart K; Bloom A; Williams AS; Hindley JP; Ondondo B; Taylor PR; Clement M; Fielding C; Godkin AJ; Jones SA; Gallimore AM. 2013. Interleukin-6 limits influenza-induced inflammation and protects against fatal lung pathology. Eur J Immunol 43(10):2613-25. [PubMed: 23857287]  [MGI Ref ID J:201665]

Lauritzen HP; Brandauer J; Schjerling P; Koh HJ; Treebak JT; Hirshman MF; Galbo H; Goodyear LJ. 2013. Contraction and AICAR stimulate IL-6 vesicle depletion from skeletal muscle fibers in vivo. Diabetes 62(9):3081-92. [PubMed: 23761105]  [MGI Ref ID J:208955]

LeBlanc RA; Pesnicak L; Cabral ES; Godleski M; Straus SE. 1999. Lack of interleukin-6 (IL-6) enhances susceptibility to infection but does not alter latency or reactivation of herpes simplex virus type 1 in IL-6 knockout mice. J Virol 73(10):8145-51. [PubMed: 10482564]  [MGI Ref ID J:57643]

Lee DL; Sturgis LC; Labazi H; Osborne JB Jr; Fleming C; Pollock JS; Manhiani M; Imig JD; Brands MW. 2006. Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. Am J Physiol Heart Circ Physiol 290(3):H935-40. [PubMed: 16284237]  [MGI Ref ID J:106719]

Lee LN; Dias P; Han D; Yoon S; Shea A; Zakharov V; Parham D; Sarawar SR. 2010. A mouse model of lethal synergism between influenza virus and Haemophilus influenzae. Am J Pathol 176(2):800-11. [PubMed: 20042666]  [MGI Ref ID J:156599]

Lee P; Peng H; Gelbart T; Beutler E. 2004. The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and beta 2-microglobulin-deficient hepatocytes. Proc Natl Acad Sci U S A 101(25):9263-5. [PubMed: 15192150]  [MGI Ref ID J:91441]

Lee P; Peng H; Gelbart T; Wang L; Beutler E. 2005. Regulation of hepcidin transcription by interleukin-1 and interleukin-6. Proc Natl Acad Sci U S A 102(6):1906-10. [PubMed: 15684062]  [MGI Ref ID J:96470]

Lee PY; Li Y; Kumagai Y; Xu Y; Weinstein JS; Kellner ES; Nacionales DC; Butfiloski EJ; van Rooijen N; Akira S; Sobel ES; Satoh M; Reeves WH. 2009. Type I interferon modulates monocyte recruitment and maturation in chronic inflammation. Am J Pathol 175(5):2023-33. [PubMed: 19808647]  [MGI Ref ID J:154704]

Lee SJ; Kim JY; Nogueiras R; Linares JF; Perez-Tilve D; Jung DY; Ko HJ; Hofmann SM; Drew A; Leitges M; Kim JK; Tschop MH; Diaz-Meco MT; Moscat J. 2010. PKCzeta-regulated inflammation in the nonhematopoietic compartment is critical for obesity-induced glucose intolerance. Cell Metab 12(1):65-77. [PubMed: 20620996]  [MGI Ref ID J:163163]

Leech MD; Barr TA; Turner DG; Brown S; O'Connor RA; Gray D; Mellanby RJ; Anderton SM. 2013. Cutting Edge: IL-6-Dependent Autoimmune Disease: Dendritic Cells as a Sufficient, but Transient, Source. J Immunol 190(3):881-5. [PubMed: 23267024]  [MGI Ref ID J:192602]

Lesina M; Kurkowski MU; Ludes K; Rose-John S; Treiber M; Kloppel G; Yoshimura A; Reindl W; Sipos B; Akira S; Schmid RM; Algul H. 2011. Stat3/Socs3 activation by IL-6 transsignaling promotes progression of pancreatic intraepithelial neoplasia and development of pancreatic cancer. Cancer Cell 19(4):456-69. [PubMed: 21481788]  [MGI Ref ID J:170981]

Li E; Zhou P; Petrin Z; Singer SM. 2004. Mast cell-dependent control of Giardia lamblia infections in mice. Infect Immun 72(11):6642-9. [PubMed: 15501797]  [MGI Ref ID J:93272]

Li E; Zhou P; Singer SM. 2006. Neuronal nitric oxide synthase is necessary for elimination of Giardia lamblia infections in mice. J Immunol 176(1):516-21. [PubMed: 16365445]  [MGI Ref ID J:126256]

Liang SC; Nickerson-Nutter C; Pittman DD; Carrier Y; Goodwin DG; Shields KM; Lambert AJ; Schelling SH; Medley QG; Ma HL; Collins M; Dunussi-Joannopoulos K; Fouser LA. 2010. IL-22 induces an acute-phase response. J Immunol 185(9):5531-8. [PubMed: 20870942]  [MGI Ref ID J:165199]

Libert C; Takahashi N; Cauwels A; Brouckaert P; Bluethmann H; Fiers W. 1994. Response of interleukin-6-deficient mice to tumor necrosis factor-induced metabolic changes and lethality. Eur J Immunol 24(9):2237-42. [PubMed: 7522168]  [MGI Ref ID J:112989]

Licata LA; Nguyen CT; Burga RA; Falanga V; Espat NJ; Ayala A; Thorn M; Junghans RP; Katz SC. 2013. Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils. J Leukoc Biol 94(4):813-23. [PubMed: 23883516]  [MGI Ref ID J:205310]

Lickteig AJ; Slitt AL; Arkan MC; Karin M; Cherrington NJ. 2007. Differential regulation of hepatic transporters in the absence of tumor necrosis factor-alpha, interleukin-1beta, interleukin-6, and nuclear factor-kappaB in two models of cholestasis. Drug Metab Dispos 35(3):402-9. [PubMed: 17151194]  [MGI Ref ID J:148159]

Liddle FJ; Frank DA. 2008. STAT1 expression is not required for polyp formation in Min mice. Mol Carcinog 47(2):75-9. [PubMed: 17683066]  [MGI Ref ID J:129797]

Lin T; Bost KL. 2004. STAT3 activation in macrophages following infection with Salmonella. Biochem Biophys Res Commun 321(4):828-34. [PubMed: 15358102]  [MGI Ref ID J:91740]

Lindroos J; Svensson L; Norsgaard H; Lovato P; Moller K; Hagedorn PH; Olsen GM; Labuda T. 2011. IL-23-mediated epidermal hyperplasia is dependent on IL-6. J Invest Dermatol 131(5):1110-8. [PubMed: 21289639]  [MGI Ref ID J:182081]

Liu X; Leung S; Wang C; Tan Z; Wang J; Guo TB; Fang L; Zhao Y; Wan B; Qin X; Lu L; Li R; Pan H; Song M; Liu A; Hong J; Lu H; Zhang JZ. 2010. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat Med 16(2):191-7. [PubMed: 20062065]  [MGI Ref ID J:157081]

Liuzzi JP; Lichten LA; Rivera S; Blanchard RK; Aydemir TB; Knutson MD; Ganz T; Cousins RJ. 2005. Interleukin-6 regulates the zinc transporter Zip14 in liver and contributes to the hypozincemia of the acute-phase response. Proc Natl Acad Sci U S A 102(19):6843-8. [PubMed: 15863613]  [MGI Ref ID J:99063]

Lochner M; Peduto L; Cherrier M; Sawa S; Langa F; Varona R; Riethmacher D; Si-Tahar M; Di Santo JP; Eberl G. 2008. In vivo equilibrium of proinflammatory IL-17+ and regulatory IL-10+ Foxp3+ RORgamma t+ T cells. J Exp Med 205(6):1381-93. [PubMed: 18504307]  [MGI Ref ID J:137020]

Lucas K; Karamichos D; Mathew R; Zieske JD; Stein-Streilein J. 2012. Retinal laser burn-induced neuropathy leads to substance P-dependent loss of ocular immune privilege. J Immunol 189(3):1237-42. [PubMed: 22745377]  [MGI Ref ID J:189781]

Mabbott NA; Williams A; Farquhar CF; Pasparakis M; Kollias G; Bruce ME. 2000. Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol 74(7):3338-44. [PubMed: 10708451]  [MGI Ref ID J:126868]

MacDuff DA; Reese TA; Kimmey JM; Weiss LA; Song C; Zhang X; Kambal A; Duan E; Carrero JA; Boisson B; Laplantine E; Israel A; Picard C; Colonna M; Edelson BT; Sibley LD; Stallings CL; Casanova JL; Iwai K; Virgin HW. 2015. Phenotypic complementation of genetic immunodeficiency by chronic herpesvirus infection. Elife 4:. [PubMed: 25599590]  [MGI Ref ID J:219574]

MacPherson RE; Castellani L; Beaudoin MS; Wright DC. 2014. Evidence for fatty acids mediating CL 316,243-induced reductions in blood glucose in mice. Am J Physiol Endocrinol Metab 307(7):E563-70. [PubMed: 25096179]  [MGI Ref ID J:219246]

Macleod MK; McKee AS; David A; Wang J; Mason R; Kappler JW; Marrack P. 2011. Vaccine adjuvants aluminum and monophosphoryl lipid A provide distinct signals to generate protective cytotoxic memory CD8 T cells. Proc Natl Acad Sci U S A 108(19):7914-9. [PubMed: 21518876]  [MGI Ref ID J:172191]

Maeda K; Baba Y; Nagai Y; Miyazaki K; Malykhin A; Nakamura K; Kincade PW; Sakaguchi N; Coggeshall KM. 2005. IL-6 blocks a discrete early step in lymphopoiesis. Blood 106(3):879-85. [PubMed: 15831701]  [MGI Ref ID J:117320]

Maeda K; Malykhin A; Teague-Weber BN; Sun XH; Farris AD; Coggeshall KM. 2009. Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. Blood 113(19):4534-40. [PubMed: 19224760]  [MGI Ref ID J:148718]

Maeda S; Hikiba Y; Shibata W; Ohmae T; Yanai A; Ogura K; Yamada S; Omata M. 2007. Essential roles of high-mobility group box 1 in the development of murine colitis and colitis-associated cancer. Biochem Biophys Res Commun 360(2):394-400. [PubMed: 17599806]  [MGI Ref ID J:123028]

Maeda S; Kamata H; Luo JL; Leffert H; Karin M. 2005. IKKbeta couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 121(7):977-90. [PubMed: 15989949]  [MGI Ref ID J:115107]

Makidon PE; Belyakov IM; Blanco LP; Janczak KW; Landers J; Bielinska AU; Groom JV 2nd; Baker JR Jr. 2012. Nanoemulsion mucosal adjuvant uniquely activates cytokine production by nasal ciliated epithelium and induces dendritic cell trafficking. Eur J Immunol 42(8):2073-86. [PubMed: 22653620]  [MGI Ref ID J:187852]

Malagarie-Cazenave S; Segui B; Leveque S; Garcia V; Carpentier S; Altie MF; Brouchet A; Gouaze V; Andrieu-Abadie N; Barreira Y; Benoist H; Levade T. 2004. Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice. J Biol Chem 279(18):18648-55. [PubMed: 14985352]  [MGI Ref ID J:89524]

Mallen-St Clair J; Pham CT; Villalta SA; Caughey GH; Wolters PJ. 2004. Mast cell dipeptidyl peptidase I mediates survival from sepsis. J Clin Invest 113(4):628-34. [PubMed: 14966572]  [MGI Ref ID J:88160]

Mari N; Hercor M; Denanglaire S; Leo O; Andris F. 2013. The capacity of Th2 lymphocytes to deliver B-cell help requires expression of the transcription factor STAT3. Eur J Immunol 43(6):1489-98. [PubMed: 23504518]  [MGI Ref ID J:198123]

Mas E; Danjoux M; Garcia V; Carpentier S; Segui B; Levade T. 2009. IL-6 deficiency attenuates murine diet-induced non-alcoholic steatohepatitis. PLoS One 4(11):e7929. [PubMed: 19936233]  [MGI Ref ID J:155402]

Matsuki T; Isoda K; Horai R; Nakajima A; Aizawa Y; Suzuki K; Ohsuzu F; Iwakura Y. 2005. Involvement of tumor necrosis factor-alpha in the development of T cell-dependent aortitis in interleukin-1 receptor antagonist-deficient mice. Circulation 112(9):1323-31. [PubMed: 16129814]  [MGI Ref ID J:118237]

Matthews VB; Allen TL; Risis S; Chan MH; Henstridge DC; Watson N; Zaffino LA; Babb JR; Boon J; Meikle PJ; Jowett JB; Watt MJ; Jansson JO; Bruce CR; Febbraio MA. 2010. Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance. Diabetologia :. [PubMed: 20697689]  [MGI Ref ID J:163838]

McBride S; Hoebe K; Georgel P; Janssen E. 2006. Cell-associated double-stranded RNA enhances antitumor activity through the production of type I IFN. J Immunol 177(9):6122-8. [PubMed: 17056539]  [MGI Ref ID J:140522]

McFarland-Mancini MM; Funk HM; Paluch AM; Zhou M; Giridhar PV; Mercer CA; Kozma SC; Drew AF. 2010. Differences in wound healing in mice with deficiency of IL-6 versus IL-6 receptor. J Immunol 184(12):7219-28. [PubMed: 20483735]  [MGI Ref ID J:160966]

McGeachy MJ; Bak-Jensen KS; Chen Y; Tato CM; Blumenschein W; McClanahan T; Cua DJ. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8(12):1390-7. [PubMed: 17994024]  [MGI Ref ID J:127772]

McGeough MD; Pena CA; Mueller JL; Pociask DA; Broderick L; Hoffman HM; Brydges SD. 2012. Cutting edge: IL-6 is a marker of inflammation with no direct role in inflammasome-mediated mouse models. J Immunol 189(6):2707-11. [PubMed: 22904305]  [MGI Ref ID J:189914]

McLoughlin RM; Jenkins BJ; Grail D; Williams AS; Fielding CA; Parker CR; Ernst M; Topley N; Jones SA. 2005. IL-6 trans-signaling via STAT3 directs T cell infiltration in acute inflammation. Proc Natl Acad Sci U S A 102(27):9589-94. [PubMed: 15976028]  [MGI Ref ID J:99865]

McLoughlin RM; Witowski J; Robson RL; Wilkinson TS; Hurst SM; Williams AS; Williams JD; Rose-John S; Jones SA; Topley N. 2003. Interplay between IFN-gamma and IL-6 signaling governs neutrophil trafficking and apoptosis during acute inflammation. J Clin Invest 112(4):598-607. [PubMed: 12925700]  [MGI Ref ID J:85159]

Meixner A; Zenz R; Schonthaler HB; Kenner L; Scheuch H; Penninger JM; Wagner EF. 2008. Epidermal JunB represses G-CSF transcription and affects haematopoiesis and bone formation. Nat Cell Biol 10(8):1003-11. [PubMed: 18641637]  [MGI Ref ID J:145478]

Mendel I; Katz A; Kozak N; Ben-Nun A; Revel M. 1998. Interleukin-6 functions in autoimmune encephalomyelitis: a study in gene-targeted mice. Eur J Immunol 28(5):1727-37. [PubMed: 9603480]  [MGI Ref ID J:119616]

Meznarich J; Malchodi L; Helterline D; Ramsey SA; Bertko K; Plummer T; Plawman A; Gold E; Stempien-Otero A. 2013. Urokinase plasminogen activator induces pro-fibrotic/m2 phenotype in murine cardiac macrophages. PLoS One 8(3):e57837. [PubMed: 23536772]  [MGI Ref ID J:199529]

Miller VM; Lawrence DA; Coccaro GA; Mondal TK; Andrews K; Dreiem A; Seegal RF. 2010. Sex effects of Interleukin-6 deficiency on neuroinflammation in aged C57Bl/6 mice. Brain Res 1318:11-22. [PubMed: 20060814]  [MGI Ref ID J:158844]

Mingam R; Moranis A; Bluthe RM; De Smedt-Peyrusse V; Kelley KW; Guesnet P; Lavialle M; Dantzer R; Laye S. 2008. Uncoupling of interleukin-6 from its signalling pathway by dietary n-3-polyunsaturated fatty acid deprivation alters sickness behaviour in mice. Eur J Neurosci 28(9):1877-86. [PubMed: 18973601]  [MGI Ref ID J:143934]

Mizoguchi A; Mizoguchi E; Takedatsu H; Blumberg RS; Bhan AK. 2002. Chronic Intestinal Inflammatory Condition Generates IL-10-Producing Regulatory B Cell Subset Characterized by CD1d Upregulation. Immunity 16(2):219-30. [PubMed: 11869683]  [MGI Ref ID J:74718]

Mizoguchi E; Mizoguchi A; Takedatsu H; Cario E; de Jong YP; Ooi CJ; Xavier RJ; Terhorst C; Podolsky DK; Bhan AK. 2002. Role of tumor necrosis factor receptor 2 (TNFR2) in colonic epithelial hyperplasia and chronic intestinal inflammation in mice. Gastroenterology 122(1):134-44. [PubMed: 11781288]  [MGI Ref ID J:73629]

Molnarfi N; Schulze-Topphoff U; Weber MS; Patarroyo JC; Prod'homme T; Varrin-Doyer M; Shetty A; Linington C; Slavin AJ; Hidalgo J; Jenne DE; Wekerle H; Sobel RA; Bernard CC; Shlomchik MJ; Zamvil SS. 2013. MHC class II-dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies. J Exp Med 210(13):2921-37. [PubMed: 24323356]  [MGI Ref ID J:211868]

Molotkov A; Satoh M; Tohyama C. 1998. Tumor growth and food intake in interleukin-6 gene knock-out mice. Cancer Lett 132(1-2):187-92. [PubMed: 10397473]  [MGI Ref ID J:51769]

Monje FJ; Cabatic M; Divisch I; Kim EJ; Herkner KR; Binder BR; Pollak DD. 2011. Constant Darkness Induces IL-6-Dependent Depression-Like Behavior through the NF-{kappa}B Signaling Pathway. J Neurosci 31(25):9075-83. [PubMed: 21697358]  [MGI Ref ID J:173524]

Morrow JD; Opp MR. 2005. Diurnal variation of lipopolysaccharide-induced alterations in sleep and body temperature of interleukin-6-deficient mice. Brain Behav Immun 19(1):40-51. [PubMed: 15581737]  [MGI Ref ID J:105273]

Morrow JD; Opp MR. 2005. Sleep-wake behavior and responses of interleukin-6-deficient mice to sleep deprivation. Brain Behav Immun 19(1):28-39. [PubMed: 15581736]  [MGI Ref ID J:105279]

Murakami M; Okuyama Y; Ogura H; Asano S; Arima Y; Tsuruoka M; Harada M; Kanamoto M; Sawa Y; Iwakura Y; Takatsu K; Kamimura D; Hirano T. 2011. Local microbleeding facilitates IL-6- and IL-17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J Exp Med 208(1):103-14. [PubMed: 21220456]  [MGI Ref ID J:176854]

Murphy PG; Ramer MS; Borthwick L; Gauldie J; Richardson PM; Bisby MA. 1999. Endogenous interleukin-6 contributes to hypersensitivity to cutaneous stimuli and changes in neuropeptides associated with chronic nerve constriction in mice. Eur J Neurosci 11(7):2243-53. [PubMed: 10383613]  [MGI Ref ID J:108089]

Murray HW. 2008. Accelerated control of visceral Leishmania donovani infection in interleukin-6-deficient mice. Infect Immun 76(9):4088-91. [PubMed: 18573898]  [MGI Ref ID J:138894]

Mysliwiec J; Zbucki R; Winnicka MM; Sawicki B; Nikolajuk A; Kaminski K; Mysliwiec P; Musial W; Bondyra Z; Walecki J; Gorska M. 2007. A crucial role of interleukin-6 in the pathogenesis of thyrotoxicosis-related disturbances of bone turnover in mice. Horm Metab Res 39(12):884-8. [PubMed: 17973207]  [MGI Ref ID J:145094]

Naik S; Bouladoux N; Wilhelm C; Molloy MJ; Salcedo R; Kastenmuller W; Deming C; Quinones M; Koo L; Conlan S; Spencer S; Hall JA; Dzutsev A; Kong H; Campbell DJ; Trinchieri G; Segre JA; Belkaid Y. 2012. Compartmentalized control of skin immunity by resident commensals. Science 337(6098):1115-9. [PubMed: 22837383]  [MGI Ref ID J:187389]

Naito Y; Takagi T; Uchiyama K; Kuroda M; Kokura S; Ichikawa H; Yanagisawa R; Inoue K; Takano H; Satoh M; Yoshida N; Okanoue T; Yoshikawa T. 2004. Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med 14(2):191-6. [PubMed: 15254764]  [MGI Ref ID J:96241]

Nakagawa T; Tsuruoka M; Ogura H; Okuyama Y; Arima Y; Hirano T; Murakami M. 2010. IL-6 positively regulates Foxp3+CD8+ T cells in vivo. Int Immunol 22(2):129-39. [PubMed: 20042455]  [MGI Ref ID J:157654]

Nakajima A; Matsuki T; Komine M; Asahina A; Horai R; Nakae S; Ishigame H; Kakuta S; Saijo S; Iwakura Y. 2010. TNF, but not IL-6 and IL-17, is crucial for the development of T cell-independent psoriasis-like dermatitis in Il1rn-/- mice. J Immunol 185(3):1887-93. [PubMed: 20610641]  [MGI Ref ID J:162246]

Nakamura K; Nonaka H; Saito H; Tanaka M; Miyajima A. 2004. Hepatocyte proliferation and tissue remodeling is impaired after liver injury in oncostatin M receptor knockout mice. Hepatology 39(3):635-44. [PubMed: 14999682]  [MGI Ref ID J:105527]

Nanjappa SG; Heninger E; Wuthrich M; Gasper DJ; Klein BS. 2012. Tc17 cells mediate vaccine immunity against lethal fungal pneumonia in immune deficient hosts lacking CD4+ T cells. PLoS Pathog 8(7):e1002771. [PubMed: 22829762]  [MGI Ref ID J:195376]

Naugler WE; Sakurai T; Kim S; Maeda S; Kim K; Elsharkawy AM; Karin M. 2007. Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science 317(5834):121-4. [PubMed: 17615358]  [MGI Ref ID J:122816]

Naz N; Malik IA; Sheikh N; Ahmad S; Khan S; Blaschke M; Schultze F; Ramadori G. 2012. Ferroportin-1 is a 'nuclear'-negative acute-phase protein in rat liver: a comparison with other iron-transport proteins. Lab Invest :. [PubMed: 22469696]  [MGI Ref ID J:184708]

Nechemia-Arbely Y; Barkan D; Pizov G; Shriki A; Rose-John S; Galun E; Axelrod JH. 2008. IL-6/IL-6R axis plays a critical role in acute kidney injury. J Am Soc Nephrol 19(6):1106-15. [PubMed: 18337485]  [MGI Ref ID J:150163]

Nemeth E; Rivera S; Gabayan V; Keller C; Taudorf S; Pedersen BK; Ganz T. 2004. IL-6 mediates hypoferremia of inflammation by inducing the synthesis of the iron regulatory hormone hepcidin. J Clin Invest 113(9):1271-6. [PubMed: 15124018]  [MGI Ref ID J:121030]

Ng CG; Griffin DE. 2006. Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis. J Virol 80(22):10989-99. [PubMed: 16943298]  [MGI Ref ID J:147397]

Nishihara M; Ogura H; Ueda N; Tsuruoka M; Kitabayashi C; Tsuji F; Aono H; Ishihara K; Huseby E; Betz UA; Murakami M; Hirano T. 2007. IL-6-gp130-STAT3 in T cells directs the development of IL-17+ Th with a minimum effect on that of Treg in the steady state. Int Immunol 19(6):695-702. [PubMed: 17493959]  [MGI Ref ID J:122296]

Nishimura N; Reeve VE; Nishimura H; Satoh M; Tohyama C. 2000. Cutaneous metallothionein induction by ultraviolet B irradiation in interleukin-6 null mice. J Invest Dermatol 114(2):343-8. [PubMed: 10651996]  [MGI Ref ID J:60195]

Nishimura N; Tohyama C; Satoh M; Nishimura H; Reeve VE. 1999. Defective immune response and severe skin damage following UVB irradiation in interleukin-6-deficient mice Immunology 97(1):77-83. [PubMed: 10447717]  [MGI Ref ID J:54607]

Nowell MA; Richards PJ; Horiuchi S; Yamamoto N; Rose-John S; Topley N; Williams AS; Jones SA. 2003. Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130. J Immunol 171(6):3202-9. [PubMed: 12960349]  [MGI Ref ID J:85371]

Nowell MA; Williams AS; Carty SA; Scheller J; Hayes AJ; Jones GW; Richards PJ; Slinn S; Ernst M; Jenkins BJ; Topley N; Rose-John S; Jones SA. 2009. Therapeutic targeting of IL-6 trans signaling counteracts STAT3 control of experimental inflammatory arthritis. J Immunol 182(1):613-22. [PubMed: 19109195]  [MGI Ref ID J:142883]

Nurieva R; Yang XO; Martinez G; Zhang Y; Panopoulos AD; Ma L; Schluns K; Tian Q; Watowich SS; Jetten AM; Dong C. 2007. Essential autocrine regulation by IL-21 in the generation of inflammatory T cells. Nature 448(7152):480-3. [PubMed: 17581589]  [MGI Ref ID J:123351]

Nurieva RI; Chung Y; Hwang D; Yang XO; Kang HS; Ma L; Wang YH; Watowich SS; Jetten AM; Tian Q; Dong C. 2008. Generation of T follicular helper cells is mediated by interleukin-21 but independent of T helper 1, 2, or 17 cell lineages. Immunity 29(1):138-49. [PubMed: 18599325]  [MGI Ref ID J:137869]

O'Brien CA; Jilka RL; Fu Q; Stewart S; Weinstein RS; Manolagas SC. 2005. IL-6 is not required for parathyroid hormone stimulation of RANKL expression, osteoclast formation, and bone loss in mice. Am J Physiol Endocrinol Metab 289(5):E784-93. [PubMed: 15956054]  [MGI Ref ID J:102452]

Ogawa H; Mukai K; Kawano Y; Minegishi Y; Karasuyama H. 2012. Th2-inducing cytokines IL-4 and IL-33 synergistically elicit the expression of transmembrane TNF-alpha on macrophages through the autocrine action of IL-6. Biochem Biophys Res Commun 420(1):114-8. [PubMed: 22405769]  [MGI Ref ID J:182581]

Ogura H; Murakami M; Okuyama Y; Tsuruoka M; Kitabayashi C; Kanamoto M; Nishihara M; Iwakura Y; Hirano T. 2008. Interleukin-17 promotes autoimmunity by triggering a positive-feedback loop via interleukin-6 induction. Immunity 29(4):628-36. [PubMed: 18848474]  [MGI Ref ID J:141114]

Ohshima S; Saeki Y; Mima T; Sasai M; Nishioka K; Nomura S; Kopf M; Katada Y; Tanaka T; Suemura M; Kishimoto T. 1998. Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A 95(14):8222-6. [PubMed: 9653168]  [MGI Ref ID J:120573]

Ohtaki H; Nakamachi T; Dohi K; Aizawa Y; Takaki A; Hodoyama K; Yofu S; Hashimoto H; Shintani N; Baba A; Kopf M; Iwakura Y; Matsuda K; Arimura A; Shioda S. 2006. Pituitary adenylate cyclase-activating polypeptide (PACAP) decreases ischemic neuronal cell death in association with IL-6. Proc Natl Acad Sci U S A 103(19):7488-93. [PubMed: 16651528]  [MGI Ref ID J:109448]

Okuda Y; Sakoda S; Bernard CC; Fujimura H; Saeki Y; Kishimoto T; Yanagihara T. 1998. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol 10(5):703-8. [PubMed: 9645618]  [MGI Ref ID J:47746]

Oldford SA; Haidl ID; Howatt MA; Leiva CA; Johnston B; Marshall JS. 2010. A Critical Role for Mast Cells and Mast Cell-Derived IL-6 in TLR2-Mediated Inhibition of Tumor Growth. J Immunol 185(11):7067-76. [PubMed: 21041732]  [MGI Ref ID J:166133]

Olivadoti MD; Opp MR. 2008. Effects of i.c.v. administration of interleukin-1 on sleep and body temperature of interleukin-6-deficient mice. Neuroscience 153(1):338-48. [PubMed: 18367337]  [MGI Ref ID J:136166]

Otero DC; Poli V; David M; Rickert RC. 2006. Cutting edge: inherent and acquired resistance to radiation-induced apoptosis in B cells: a pivotal role for STAT3. J Immunol 177(10):6593-7. [PubMed: 17082570]  [MGI Ref ID J:140502]

Parish CL; Finkelstein DI; Tripanichkul W; Satoskar AR; Drago J; Horne MK. 2002. The role of interleukin-1, interleukin-6, and glia in inducing growth of neuronal terminal arbors in mice. J Neurosci 22(18):8034-41. [PubMed: 12223557]  [MGI Ref ID J:79142]

Park SJ; Nakagawa T; Kitamura H; Atsumi T; Kamon H; Sawa S; Kamimura D; Ueda N; Iwakura Y; Ishihara K; Murakami M; Hirano T. 2004. IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173(6):3844-54. [PubMed: 15356132]  [MGI Ref ID J:92764]

Park SW; Chen SW; Kim M; Brown KM; Kolls JK; D'Agati VD; Lee HT. 2011. Cytokines induce small intestine and liver injury after renal ischemia or nephrectomy. Lab Invest 91(1):63-84. [PubMed: 20697374]  [MGI Ref ID J:167189]

Passos ST; Silver JS; O'Hara AC; Sehy D; Stumhofer JS; Hunter CA. 2010. IL-6 promotes NK cell production of IL-17 during toxoplasmosis. J Immunol 184(4):1776-83. [PubMed: 20083665]  [MGI Ref ID J:159481]

Pavelko KD; Howe CL; Drescher KM; Gamez JD; Johnson AJ; Wei T; Ransohoff RM; Rodriguez M. 2003. Interleukin-6 protects anterior horn neurons from lethal virus-induced injury. J Neurosci 23(2):481-92. [PubMed: 12533608]  [MGI Ref ID J:81740]

Pawlik TM; Carter EA; Bode BP; Fischman AJ; Tompkins RG. 2003. Central role of interleukin-6 in burn induced stimulation of hepatic amino acid transport. Int J Mol Med 12(4):541-8. [PubMed: 12964032]  [MGI Ref ID J:113636]

Pazos P; Lima L; Casanueva FF; Dieguez C; Garcia MC. 2013. Interleukin 6 deficiency modulates the hypothalamic expression of energy balance regulating peptides during pregnancy in mice. PLoS One 8(8):e72339. [PubMed: 24015235]  [MGI Ref ID J:206409]

Pedchenko TV; LeVine SM. 1999. IL-6 deficiency causes enhanced pathology in Twitcher (globoid cell leukodystrophy) mice. Exp Neurol 158(2):459-68. [PubMed: 10415153]  [MGI Ref ID J:56656]

Pedersen L; Pilegaard H; Hansen J; Brandt C; Adser H; Hidalgo J; Olesen J; Pedersen BK; Hojman P. 2011. Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. J Physiol 589(Pt 6):1409-20. [PubMed: 21224226]  [MGI Ref ID J:183135]

Pedroza M; Schneider DJ; Karmouty-Quintana H; Coote J; Shaw S; Corrigan R; Molina JG; Alcorn JL; Galas D; Gelinas R; Blackburn MR. 2011. Interleukin-6 contributes to inflammation and remodeling in a model of adenosine mediated lung injury. PLoS One 6(7):e22667. [PubMed: 21799929]  [MGI Ref ID J:175762]

Peng X; Xiao Z; Zhang J; Li Y; Dong Y; Du J. 2015. IL-17A produced by both gammadelta T and Th17 cells promotes renal fibrosis via RANTES-mediated leukocyte infiltration after renal obstruction. J Pathol 235(1):79-89. [PubMed: 25158055]  [MGI Ref ID J:216159]

Penkowa M; Molinero A; Carrasco J; Hidalgo J. 2001. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience 102(4):805-18. [PubMed: 11182244]  [MGI Ref ID J:126696]

Penkowa M; Moos T; Carrasco J; Hadberg H; Molinero A; Bluethmann H; Hidalgo J. 1999. Strongly compromised inflammatory response to brain injury in interleukin-6-deficient mice. Glia 25(4):343-57. [PubMed: 10028917]  [MGI Ref ID J:53679]

Peperzak V; Vikstrom I; Walker J; Glaser SP; Lepage M; Coquery CM; Erickson LD; Fairfax K; Mackay F; Strasser A; Nutt SL; Tarlinton DM. 2013. Mcl-1 is essential for the survival of plasma cells. Nat Immunol 14(3):290-7. [PubMed: 23377201]  [MGI Ref ID J:193618]

Persson EK; Uronen-Hansson H; Semmrich M; Rivollier A; Hagerbrand K; Marsal J; Gudjonsson S; Hakansson U; Reizis B; Kotarsky K; Agace WW. 2013. IRF4 transcription-factor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity 38(5):958-69. [PubMed: 23664832]  [MGI Ref ID J:203154]

Petermann F; Rothhammer V; Claussen MC; Haas JD; Blanco LR; Heink S; Prinz I; Hemmer B; Kuchroo VK; Oukka M; Korn T. 2010. gammadelta T cells enhance autoimmunity by restraining regulatory T cell responses via an interleukin-23-dependent mechanism. Immunity 33(3):351-63. [PubMed: 20832339]  [MGI Ref ID J:164420]

Peters T; Bloch W; Wickenhauser C; Tawadros S; Oreshkova T; Kess D; Krieg T; Muller W; Scharffetter-Kochanek K. 2006. Terminal B cell differentiation is skewed by deregulated interleukin-6 secretion in beta2 integrin-deficient mice. J Leukoc Biol 80(3):599-607. [PubMed: 16844762]  [MGI Ref ID J:112667]

Pflegerl P; Vesely P; Hantusch B; Schlederer M; Zenz R; Janig E; Steiner G; Meixner A; Petzelbauer P; Wolf P; Soleiman A; Egger G; Moriggl R; Kishimoto T; Wagner EF; Kenner L. 2009. Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signaling. Proc Natl Acad Sci U S A 106(48):20423-8. [PubMed: 19918056]  [MGI Ref ID J:155575]

Pickert G; Neufert C; Leppkes M; Zheng Y; Wittkopf N; Warntjen M; Lehr HA; Hirth S; Weigmann B; Wirtz S; Ouyang W; Neurath MF; Becker C. 2009. STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J Exp Med 206(7):1465-72. [PubMed: 19564350]  [MGI Ref ID J:150265]

Poffenberger MC; Straka N; El Warry N; Fang D; Shanina I; Horwitz MS. 2009. Lack of IL-6 during coxsackievirus infection heightens the early immune response resulting in increased severity of chronic autoimmune myocarditis. PLoS One 4(7):e6207. [PubMed: 19587788]  [MGI Ref ID J:151607]

Poholek AC; Hansen K; Hernandez SG; Eto D; Chandele A; Weinstein JS; Dong X; Odegard JM; Kaech SM; Dent AL; Crotty S; Craft J. 2010. In vivo regulation of Bcl6 and T follicular helper cell development. J Immunol 185(1):313-26. [PubMed: 20519643]  [MGI Ref ID J:161433]

Poudrier J; Weng X; Kay DG; Pare G; Calvo EL; Hanna Z; Kosco-Vilbois MH; Jolicoeur P. 2001. The AIDS disease of CD4C/HIV transgenic mice shows impaired germinal centers and autoantibodies and develops in the absence of IFN-gamma and IL-6. Immunity 15(2):173-85. [PubMed: 11520454]  [MGI Ref ID J:131516]

Powolny-Budnicka I; Riemann M; Tanzer S; Schmid RM; Hehlgans T; Weih F. 2011. RelA and RelB Transcription Factors in Distinct Thymocyte Populations Control Lymphotoxin-Dependent Interleukin-17 Production in gammadelta T Cells. Immunity 34(3):364-74. [PubMed: 21419662]  [MGI Ref ID J:169863]

Putoczki TL; Thiem S; Loving A; Busuttil RA; Wilson NJ; Ziegler PK; Nguyen PM; Preaudet A; Farid R; Edwards KM; Boglev Y; Luwor RB; Jarnicki A; Horst D; Boussioutas A; Heath JK; Sieber OM; Pleines I; Kile BT; Nash A; Greten FR; McKenzie BS; Ernst M. 2013. Interleukin-11 is the dominant IL-6 family cytokine during gastrointestinal tumorigenesis and can be targeted therapeutically. Cancer Cell 24(2):257-71. [PubMed: 23948300]  [MGI Ref ID J:202609]

Quante M; Bhagat G; Abrams JA; Marache F; Good P; Lee MD; Lee Y; Friedman R; Asfaha S; Dubeykovskaya Z; Mahmood U; Figueiredo JL; Kitajewski J; Shawber C; Lightdale CJ; Rustgi AK; Wang TC. 2012. Bile Acid and inflammation activate gastric cardia stem cells in a mouse model of barrett-like metaplasia. Cancer Cell 21(1):36-51. [PubMed: 22264787]  [MGI Ref ID J:180282]

Quinton LJ; Jones MR; Robson BE; Mizgerd JP. 2009. Mechanisms of the hepatic acute-phase response during bacterial pneumonia. Infect Immun 77(6):2417-26. [PubMed: 19289507]  [MGI Ref ID J:149372]

Rachitskaya AV; Hansen AM; Horai R; Li Z; Villasmil R; Luger D; Nussenblatt RB; Caspi RR. 2008. Cutting edge: NKT cells constitutively express IL-23 receptor and RORgammat and rapidly produce IL-17 upon receptor ligation in an IL-6-independent fashion. J Immunol 180(8):5167-71. [PubMed: 18390697]  [MGI Ref ID J:134247]

Ramadori P; Ahmad G; Ramadori G. 2010. Cellular and molecular mechanisms regulating the hepatic erythropoietin expression during acute-phase response: a role for IL-6. Lab Invest 90(9):1306-24. [PubMed: 20458283]  [MGI Ref ID J:163425]

Ramer MS; Murphy PG; Richardson PM; Bisby MA. 1998. Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 78(2):115-21. [PubMed: 9839821]  [MGI Ref ID J:54735]

Ramsay AJ; Husband AJ; Ramshaw IA; Bao S; Matthaei KI; Koehler G; Kopf M. 1994. The role of interleukin-6 in mucosal IgA antibody responses in vivo. Science 264(5158):561-3. [PubMed: 8160012]  [MGI Ref ID J:17860]

Ranganathan P; Jayakumar C; Santhakumar M; Ramesh G. 2013. Netrin-1 regulates colon-kidney cross talk through suppression of IL-6 function in a mouse model of DSS-colitis. Am J Physiol Renal Physiol 304(9):F1187-97. [PubMed: 23445618]  [MGI Ref ID J:197266]

Reeve VE; Tyrrell RM; Allanson M; Domanski D; Blyth L. 2009. The role of interleukin-6 in UVA protection against UVB-induced immunosuppression. J Invest Dermatol 129(6):1539-46. [PubMed: 19110542]  [MGI Ref ID J:151052]

Reil JC; Gilles S; Zahler S; Brandl A; Drexler H; Hultner L; Matrisian LM; Welsch U; Becker BF. 2007. Insights from knock-out models concerning postischemic release of TNFalpha from isolated mouse hearts. J Mol Cell Cardiol 42(1):133-41. [PubMed: 17101148]  [MGI Ref ID J:119661]

Remick DG; Bolgos G; Copeland S; Siddiqui J. 2005. Role of interleukin-6 in mortality from and physiologic response to sepsis. Infect Immun 73(5):2751-7. [PubMed: 15845478]  [MGI Ref ID J:97611]

Ren X; Hogaboam C; Carpenter A; Colletti L. 2003. Stem cell factor restores hepatocyte proliferation in IL-6 knockout mice following 70% hepatectomy. J Clin Invest 112(9):1407-18. [PubMed: 14597766]  [MGI Ref ID J:118475]

Reynaud D; Pietras E; Barry-Holson K; Mir A; Binnewies M; Jeanne M; Sala-Torra O; Radich JP; Passegue E. 2011. IL-6 controls leukemic multipotent progenitor cell fate and contributes to chronic myelogenous leukemia development. Cancer Cell 20(5):661-73. [PubMed: 22094259]  [MGI Ref ID J:178950]

Riol-Blanco L; Lazarevic V; Awasthi A; Mitsdoerffer M; Wilson BS; Croxford A; Waisman A; Kuchroo VK; Glimcher LH; Oukka M. 2010. IL-23 receptor regulates unconventional IL-17-producing T cells that control bacterial infections. J Immunol 184(4):1710-20. [PubMed: 20083652]  [MGI Ref ID J:159487]

Riordan JD; Nadeau JH. 2014. Modeling progressive non-alcoholic fatty liver disease in the laboratory mouse. Mamm Genome 25(9-10):473-86. [PubMed: 24802098]  [MGI Ref ID J:216841]

Robertson SA; Christiaens I; Dorian CL; Zaragoza DB; Care AS; Banks AM; Olson DM. 2010. Interleukin-6 is an essential determinant of on-time parturition in the mouse. Endocrinology 151(8):3996-4006. [PubMed: 20610570]  [MGI Ref ID J:168514]

Rodriguez Mdel C; Bernad A; Aracil M. 2004. Interleukin-6 deficiency affects bone marrow stromal precursors, resulting in defective hematopoietic support. Blood 103(9):3349-54. [PubMed: 14701687]  [MGI Ref ID J:90289]

Rodriguez R; Jung CL; Gabayan V; Deng JC; Ganz T; Nemeth E; Bulut Y. 2014. Hepcidin induction by pathogens and pathogen-derived molecules is strongly dependent on interleukin-6. Infect Immun 82(2):745-52. [PubMed: 24478088]  [MGI Ref ID J:209811]

Rojas M; Zhang W; Lee DL; Romero MJ; Nguyen DT; Al-Shabrawey M; Tsai NT; Liou GI; Brands MW; Caldwell RW; Caldwell RB. 2010. Role of IL-6 in angiotensin II-induced retinal vascular inflammation. Invest Ophthalmol Vis Sci 51(3):1709-18. [PubMed: 19834028]  [MGI Ref ID J:160419]

Rosborough BR; Raich-Regue D; Matta BM; Lee K; Gan B; DePinho RA; Hackstein H; Boothby M; Turnquist HR; Thomson AW. 2013. Murine dendritic cell rapamycin-resistant and rictor-independent mTOR controls IL-10, B7-H1, and regulatory T-cell induction. Blood 121(18):3619-30. [PubMed: 23444404]  [MGI Ref ID J:197572]

Rosean TR; Tompkins VS; Olivier AK; Sompallae R; Norian LA; Morse HC 3rd; Waldschmidt TJ; Janz S. 2015. The tumor microenvironment is the main source of IL-6 for plasma cell tumor development in mice. Leukemia 29(1):233-7. [PubMed: 25257990]  [MGI Ref ID J:217194]

Rosenbaum JT; Kievit P; Han YB; Park JM; Planck SR. 1998. Interleukin-6 does not mediate endotoxin-induced uveitis in mice: studies in gene deletion animals. Invest Ophthalmol Vis Sci 39(1):64-9. [PubMed: 9430546]  [MGI Ref ID J:45408]

Rozanski CH; Arens R; Carlson LM; Nair J; Boise LH; Chanan-Khan AA; Schoenberger SP; Lee KP. 2011. Sustained antibody responses depend on CD28 function in bone marrow-resident plasma cells. J Exp Med 208(7):1435-46. [PubMed: 21690252]  [MGI Ref ID J:176810]

Ruwanpura SM; McLeod L; Miller A; Jones J; Bozinovski S; Vlahos R; Ernst M; Armes J; Bardin PG; Anderson GP; Jenkins BJ. 2011. Interleukin-6 promotes pulmonary emphysema associated with apoptosis in mice. Am J Respir Cell Mol Biol 45(4):720-30. [PubMed: 21297079]  [MGI Ref ID J:190215]

Ruwanpura SM; McLeod L; Miller A; Jones J; Vlahos R; Ramm G; Longano A; Bardin PG; Bozinovski S; Anderson GP; Jenkins BJ. 2012. Deregulated Stat3 signaling dissociates pulmonary inflammation from emphysema in gp130 mutant mice. Am J Physiol Lung Cell Mol Physiol 302(7):L627-39. [PubMed: 22268122]  [MGI Ref ID J:183951]

Sadler AJ; Rossello FJ; Yu L; Deane JA; Yuan X; Wang D; Irving AT; Kaparakis-Liaskos M; Gantier MP; Ying H; Yim HC; Hartland EL; Notini AJ; de Boer S; White SJ; Mansell A; Liu JP; Watkins DN; Gerondakis S; Williams BR; Xu D. 2015. BTB-ZF transcriptional regulator PLZF modifies chromatin to restrain inflammatory signaling programs. Proc Natl Acad Sci U S A 112(5):1535-40. [PubMed: 25605927]  [MGI Ref ID J:217661]

Saito F; Tasaka S; Inoue K; Miyamoto K; Nakano Y; Ogawa Y; Yamada W; Shiraishi Y; Hasegawa N; Fujishima S; Takano H; Ishizaka A. 2008. Role of interleukin-6 in bleomycin-induced lung inflammatory changes in mice. Am J Respir Cell Mol Biol 38(5):566-71. [PubMed: 18096870]  [MGI Ref ID J:149720]

Saito H; Patterson C; Hu Z; Runge MS; Tipnis U; Sinha M; Papaconstantinou J. 2000. Expression and self-regulatory function of cardiac interleukin-6 during endotoxemia. Am J Physiol Heart Circ Physiol 279(5):H2241-8. [PubMed: 11045959]  [MGI Ref ID J:108274]

Salomon R; Hoffmann E; Webster RG. 2007. Inhibition of the cytokine response does not protect against lethal H5N1 influenza infection. Proc Natl Acad Sci U S A 104(30):12479-81. [PubMed: 17640882]  [MGI Ref ID J:123301]

Samoilova EB; Horton JL; Hilliard B; Liu TS; Chen Y. 1998. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 161(12):6480-6. [PubMed: 9862671]  [MGI Ref ID J:110811]

Sanders CJ; Moore DA 3rd; Williams IR; Gewirtz AT. 2008. Both radioresistant and hemopoietic cells promote innate and adaptive immune responses to flagellin. J Immunol 180(11):7184-92. [PubMed: 18490717]  [MGI Ref ID J:136347]

Sangaletti S; Tripodo C; Chiodoni C; Guarnotta C; Cappetti B; Casalini P; Piconese S; Parenza M; Guiducci C; Vitali C; Colombo MP. 2012. Neutrophil extracellular traps mediate transfer of cytoplasmic neutrophil antigens to myeloid dendritic cells toward ANCA induction and associated autoimmunity. Blood 120(15):3007-18. [PubMed: 22932797]  [MGI Ref ID J:192930]

Sanos SL; Bui VL; Mortha A; Oberle K; Heners C; Johner C; Diefenbach A. 2009. RORgammat and commensal microflora are required for the differentiation of mucosal interleukin 22-producing NKp46+ cells. Nat Immunol 10(1):83-91. [PubMed: 19029903]  [MGI Ref ID J:142348]

Sartorius T; Lutz SZ; Hoene M; Waak J; Peter A; Weigert C; Rammensee HG; Kahle PJ; Haring HU; Hennige AM. 2012. Toll-like receptors 2 and 4 impair insulin-mediated brain activity by interleukin-6 and osteopontin and alter sleep architecture. FASEB J 26(5):1799-809. [PubMed: 22278939]  [MGI Ref ID J:183285]

Satoh-Takayama N; Vosshenrich CA; Lesjean-Pottier S; Sawa S; Lochner M; Rattis F; Mention JJ; Thiam K; Cerf-Bensussan N; Mandelboim O; Eberl G; Di Santo JP. 2008. Microbial flora drives interleukin 22 production in intestinal NKp46+ cells that provide innate mucosal immune defense. Immunity 29(6):958-70. [PubMed: 19084435]  [MGI Ref ID J:142654]

Sawa S; Kamimura D; Jin GH; Morikawa H; Kamon H; Nishihara M; Ishihara K; Murakami M; Hirano T. 2006. Autoimmune arthritis associated with mutated interleukin (IL)-6 receptor gp130 is driven by STAT3/IL-7-dependent homeostatic proliferation of CD4+ T cells. J Exp Med 203(6):1459-70. [PubMed: 16717113]  [MGI Ref ID J:124381]

Schepers K; Pietras EM; Reynaud D; Flach J; Binnewies M; Garg T; Wagers AJ; Hsiao EC; Passegue E. 2013. Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche. Cell Stem Cell 13(3):285-99. [PubMed: 23850243]  [MGI Ref ID J:201668]

Schieffer B; Selle T; Hilfiker A; Hilfiker-Kleiner D; Grote K; Tietge UJ; Trautwein C; Luchtefeld M; Schmittkamp C; Heeneman S; Daemen MJ; Drexler H. 2004. Impact of interleukin-6 on plaque development and morphology in experimental atherosclerosis. Circulation 110(22):3493-500. [PubMed: 15557373]  [MGI Ref ID J:103918]

Schmidt C; Hocherl K; Bucher M. 2007. Cytokine-mediated regulation of urea transporters during experimental endotoxemia. Am J Physiol Renal Physiol 292(5):F1479-89. [PubMed: 17229673]  [MGI Ref ID J:121446]

Schmitz I; Schneider C; Frohlich A; Frebel H; Christ D; Leonard WJ; Sparwasser T; Oxenius A; Freigang S; Kopf M. 2013. IL-21 restricts virus-driven Treg cell expansion in chronic LCMV infection. PLoS Pathog 9(5):e1003362. [PubMed: 23696736]  [MGI Ref ID J:213404]

Sekiya S; Suzuki A. 2011. Glycogen synthase kinase 3{beta}-dependent Snail degradation directs hepatocyte proliferation in normal liver regeneration. Proc Natl Acad Sci U S A 108(27):11175-80. [PubMed: 21690373]  [MGI Ref ID J:174303]

Sellge G; Magalhaes JG; Konradt C; Fritz JH; Salgado-Pabon W; Eberl G; Bandeira A; Di Santo JP; Sansonetti PJ; Phalipon A. 2010. Th17 cells are the dominant T cell subtype primed by Shigella flexneri mediating protective immunity. J Immunol 184(4):2076-85. [PubMed: 20089698]  [MGI Ref ID J:159474]

Senchenkova EY; Komoto S; Russell J; Almeida-Paula LD; Yan LS; Zhang S; Granger DN. 2013. Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis. Am J Pathol 183(1):173-81. [PubMed: 23673000]  [MGI Ref ID J:197424]

Serrano AL; Baeza-Raja B; Perdiguero E; Jardi M; Munoz-Canoves P. 2008. Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7(1):33-44. [PubMed: 18177723]  [MGI Ref ID J:131016]

Shafiani S; Dinh C; Ertelt JM; Moguche AO; Siddiqui I; Smigiel KS; Sharma P; Campbell DJ; Way SS; Urdahl KB. 2013. Pathogen-specific Treg cells expand early during mycobacterium tuberculosis infection but are later eliminated in response to Interleukin-12. Immunity 38(6):1261-70. [PubMed: 23791647]  [MGI Ref ID J:207578]

Shao R; Nutu M; Karlsson-Lindahl L; Benrick A; Weijdegard B; Lager S; Egecioglu E; Fernandez-Rodriguez J; Gemzell-Danielsson K; Ohlsson C; Jansson JO; Billig H. 2009. Downregulation of cilia-localized Il-6R alpha by 17beta-estradiol in mouse and human fallopian tubes. Am J Physiol Cell Physiol 297(1):C140-51. [PubMed: 19420002]  [MGI Ref ID J:151176]

Sharma MD; Hou DY; Baban B; Koni PA; He Y; Chandler PR; Blazar BR; Mellor AL; Munn DH. 2010. Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice. Immunity 33(6):942-54. [PubMed: 21145762]  [MGI Ref ID J:167291]

Shaw MH; Kamada N; Kim YG; Nunez G. 2012. Microbiota-induced IL-1beta, but not IL-6, is critical for the development of steady-state TH17 cells in the intestine. J Exp Med 209(2):251-8. [PubMed: 22291094]  [MGI Ref ID J:181869]

Shichita T; Sugiyama Y; Ooboshi H; Sugimori H; Nakagawa R; Takada I; Iwaki T; Okada Y; Iida M; Cua DJ; Iwakura Y; Yoshimura A. 2009. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat Med 15(8):946-50. [PubMed: 19648929]  [MGI Ref ID J:152082]

Shore SA; Lang JE; Kasahara DI; Lu FL; Verbout NG; Si H; Williams ES; Terry RD; Lee A; Johnston RA. 2009. Pulmonary responses to subacute ozone exposure in obese vs. lean mice. J Appl Physiol 107(5):1445-52. [PubMed: 19745193]  [MGI Ref ID J:177975]

Siebert H; Bruck W. 2003. The role of cytokines and adhesion molecules in axon degeneration after peripheral nerve axotomy: a study in different knockout mice. Brain Res 960(1-2):152-6. [PubMed: 12505667]  [MGI Ref ID J:107780]

Siewert E; Dietrich CG; Lammert F; Heinrich PC; Matern S; Gartung C; Geier A. 2004. Interleukin-6 regulates hepatic transporters during acute-phase response. Biochem Biophys Res Commun 322(1):232-8. [PubMed: 15313196]  [MGI Ref ID J:113760]

Sims NA; Jenkins BJ; Nakamura A; Quinn JM; Li R; Gillespie MT; Ernst M; Robb L; Martin TJ. 2005. Interleukin-11 receptor signaling is required for normal bone remodeling. J Bone Miner Res 20(7):1093-102. [PubMed: 15940362]  [MGI Ref ID J:111457]

Sims NA; Jenkins BJ; Quinn JM; Nakamura A; Glatt M; Gillespie MT; Ernst M; Martin TJ. 2004. Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest 113(3):379-89. [PubMed: 14755335]  [MGI Ref ID J:87612]

Slight SR; Rangel-Moreno J; Gopal R; Lin Y; Fallert Junecko BA; Mehra S; Selman M; Becerril-Villanueva E; Baquera-Heredia J; Pavon L; Kaushal D; Reinhart TA; Randall TD; Khader SA. 2013. CXCR5+ T helper cells mediate protective immunity against tuberculosis. J Clin Invest :. [PubMed: 23281399]  [MGI Ref ID J:194502]

Smith AL; Hayday AC. 2000. Genetic dissection of primary and secondary responses to a widespread natural pathogen of the gut, Eimeria vermiformis. Infect Immun 68(11):6273-80. [PubMed: 11035735]  [MGI Ref ID J:133107]

Smith CL; Arvedson TL; Cooke KS; Dickmann LJ; Forte C; Li H; Merriam KL; Perry VK; Tran L; Rottman JB; Maxwell JR. 2013. IL-22 regulates iron availability in vivo through the induction of hepcidin. J Immunol 191(4):1845-55. [PubMed: 23836059]  [MGI Ref ID J:205704]

Smith KA; Maizels RM. 2014. IL-6 controls susceptibility to helminth infection by impeding Th2 responsiveness and altering the Treg phenotype in vivo. Eur J Immunol 44(1):150-61. [PubMed: 24185641]  [MGI Ref ID J:209008]

Sparkman NL; Buchanan JB; Heyen JR; Chen J; Beverly JL; Johnson RW. 2006. Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci 26(42):10709-16. [PubMed: 17050710]  [MGI Ref ID J:113436]

Spehlmann ME; Manthey CF; Dann SM; Hanson E; Sandhu SS; Liu LY; Abdelmalak FK; Diamanti MA; Retzlaff K; Scheller J; Rose-John S; Greten FR; Wang JY; Eckmann L. 2013. Trp53 deficiency protects against acute intestinal inflammation. J Immunol 191(2):837-47. [PubMed: 23772033]  [MGI Ref ID J:204954]

Spence S; Fitzsimons A; Boyd CR; Kessler J; Fitzgerald D; Elliott J; Gabhann JN; Smith S; Sica A; Hams E; Saunders SP; Jefferies CA; Fallon PG; McAuley DF; Kissenpfennig A; Johnston JA. 2013. Suppressors of cytokine signaling 2 and 3 diametrically control macrophage polarization. Immunity 38(1):66-78. [PubMed: 23177319]  [MGI Ref ID J:192314]

Sporri R; Joller N; Albers U; Hilbi H; Oxenius A. 2006. MyD88-dependent IFN-gamma production by NK cells is key for control of Legionella pneumophila infection. J Immunol 176(10):6162-71. [PubMed: 16670325]  [MGI Ref ID J:131762]

Sprando RL; Pestka J; Collins TF; Rorie J; O'Donnell M; Hinton D; Chirtel S. 1999. The effect of vomitoxin (Deoxnivalenol) on testicular morphology, testicular spermatid counts and epididymal sperm counts in IL-6KO [B6129-IL6 [TmlKopf] (IL-6 gene deficient)] and WT [B6129F2 (wild type to B6129-IL6 with an intact IL-6 gene)] mice. Food Chem Toxicol 37(11):1073-9. [PubMed: 10566878]  [MGI Ref ID J:59653]

Stager S; Maroof A; Zubairi S; Sanos SL; Kopf M; Kaye PM. 2006. Distinct roles for IL-6 and IL-12p40 in mediating protection against Leishmania donovani and the expansion of IL-10+ CD4+ T cells. Eur J Immunol 36(7):1764-71. [PubMed: 16791879]  [MGI Ref ID J:115789]

Stahel PF; Shohami E; Younis FM; Kariya K; Otto VI; Lenzlinger PM; Grosjean MB; Eugster HP; Trentz O; Kossmann T; Morganti-Kossmann MC. 2000. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for pro-inflammatory cytokines. J Cereb Blood Flow Metab 20(2):369-80. [PubMed: 10698075]  [MGI Ref ID J:61314]

Stanford KI; Middelbeek RJ; Townsend KL; An D; Nygaard EB; Hitchcox KM; Markan KR; Nakano K; Hirshman MF; Tseng YH; Goodyear LJ. 2013. Brown adipose tissue regulates glucose homeostasis and insulin sensitivity. J Clin Invest 123(1):215-23. [PubMed: 23221344]  [MGI Ref ID J:194154]

Suda K; Tsuruta M; Eom J; Or C; Mui T; Jaw JE; Li Y; Bai N; Kim J; Man J; Ngan D; Lee J; Hansen S; Lee SW; Tam S; Man SP; Van Eeden S; Sin DD. 2011. Acute lung injury induces cardiovascular dysfunction: effects of IL-6 and budesonide/formoterol. Am J Respir Cell Mol Biol 45(3):510-6. [PubMed: 21169556]  [MGI Ref ID J:190225]

Sudo K; Yamada Y; Saito K; Shimizu S; Ohashi H; Kato T; Moriwaki H; Ito H; Seishima M. 2008. TNF-alpha and IL-6 signals from the bone marrow derived cells are necessary for normal murine liver regeneration. Biochim Biophys Acta 1782(11):671-9. [PubMed: 18948191]  [MGI Ref ID J:143784]

Sugiura S; Lahav R; Han J; Kou SY; Banner LR; de Pablo F; Patterson PH. 2000. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci 12(2):457-66. [PubMed: 10712626]  [MGI Ref ID J:89814]

Sun J; Sukhova GK; Wolters PJ; Yang M; Kitamoto S; Libby P; MacFarlane LA; Mallen-St Clair J; Shi GP. 2007. Mast cells promote atherosclerosis by releasing proinflammatory cytokines. Nat Med 13(6):719-24. [PubMed: 17546038]  [MGI Ref ID J:125116]

Sun J; Sukhova GK; Yang M; Wolters PJ; MacFarlane LA; Libby P; Sun C; Zhang Y; Liu J; Ennis TL; Knispel R; Xiong W; Thompson RW; Baxter BT; Shi GP. 2007. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 117(11):3359-68. [PubMed: 17932568]  [MGI Ref ID J:127400]

Sun Y; Varambally S; Maher CA; Cao Q; Chockley P; Toubai T; Malter C; Nieves E; Tawara I; Wang Y; Ward PA; Chinnaiyan A; Reddy P. 2011. Targeting of microRNA-142-3p in dendritic cells regulates endotoxin-induced mortality. Blood 117(23):6172-83. [PubMed: 21474672]  [MGI Ref ID J:174716]

Suthaus J; Stuhlmann-Laeisz C; Tompkins VS; Rosean TR; Klapper W; Tosato G; Janz S; Scheller J; Rose-John S. 2012. HHV-8-encoded viral IL-6 collaborates with mouse IL-6 in the development of multicentric Castleman disease in mice. Blood 119(22):5173-81. [PubMed: 22490805]  [MGI Ref ID J:185153]

Sutherland RE; Olsen JS; McKinstry A; Villalta SA; Wolters PJ. 2008. Mast cell IL-6 improves survival from Klebsiella pneumonia and sepsis by enhancing neutrophil killing. J Immunol 181(8):5598-605. [PubMed: 18832718]  [MGI Ref ID J:140758]

Suzuki M; Sugimoto Y; Ohsaki Y; Ueno M; Kato S; Kitamura Y; Hosokawa H; Davies JP; Ioannou YA; Vanier MT; Ohno K; Ninomiya H. 2007. Endosomal accumulation of Toll-like receptor 4 causes constitutive secretion of cytokines and activation of signal transducers and activators of transcription in Niemann-Pick disease type C (NPC) fibroblasts: a potential basis for glial cell activation in the NPC brain. J Neurosci 27(8):1879-91. [PubMed: 17314284]  [MGI Ref ID J:118352]

Swartz KR; Liu F; Sewell D; Schochet T; Campbell I; Sandor M; Fabry Z. 2001. Interleukin-6 promotes post-traumatic healing in the central nervous system. Brain Res 896(1-2):86-95. [PubMed: 11277977]  [MGI Ref ID J:68649]

Swiergiel AH; Dunn AJ. 2006. Feeding, exploratory, anxiety- and depression-related behaviors are not altered in interleukin-6-deficient male mice. Behav Brain Res 171(1):94-108. [PubMed: 16677721]  [MGI Ref ID J:108975]

Szretter KJ; Gangappa S; Lu X; Smith C; Shieh WJ; Zaki SR; Sambhara S; Tumpey TM; Katz JM. 2007. Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice. J Virol 81(6):2736-44. [PubMed: 17182684]  [MGI Ref ID J:153325]

Tadokoro T; Wang Y; Barak LS; Bai Y; Randell SH; Hogan BL. 2014. IL-6/STAT3 promotes regeneration of airway ciliated cells from basal stem cells. Proc Natl Acad Sci U S A 111(35):E3641-9. [PubMed: 25136113]  [MGI Ref ID J:214820]

Takaoka M; Suzuki H; Shioda S; Sekikawa K; Saito Y; Nagai R; Sata M. 2010. Endovascular injury induces rapid phenotypic changes in perivascular adipose tissue. Arterioscler Thromb Vasc Biol 30(8):1576-82. [PubMed: 20489168]  [MGI Ref ID J:179555]

Tan X; Carretero J; Chen Z; Zhang J; Wang Y; Chen J; Li X; Ye H; Tang C; Cheng X; Hou N; Yang X; Wong KK. 2013. Loss of p53 attenuates the contribution of IL-6 deletion on suppressed tumor progression and extended survival in Kras-driven murine lung cancer. PLoS One 8(11):e80885. [PubMed: 24260500]  [MGI Ref ID J:206730]

Tanaka S; Yoshimoto T; Naka T; Nakae S; Iwakura Y; Cua D; Kubo M. 2009. Natural occurring IL-17 producing T cells regulate the initial phase of neutrophil mediated airway responses. J Immunol 183(11):7523-30. [PubMed: 19890042]  [MGI Ref ID J:157401]

Taylor PR; Roy S; Leal SM Jr; Sun Y; Howell SJ; Cobb BA; Li X; Pearlman E. 2014. Activation of neutrophils by autocrine IL-17A-IL-17RC interactions during fungal infection is regulated by IL-6, IL-23, RORgammat and dectin-2. Nat Immunol 15(2):143-51. [PubMed: 24362892]  [MGI Ref ID J:209279]

TeKippe M; Harrison DE; Chen J. 2003. Expansion of hematopoietic stem cell phenotype and activity in Trp53-null mice. Exp Hematol 31(6):521-7. [PubMed: 12829028]  [MGI Ref ID J:115677]

Tebbutt NC; Giraud AS; Inglese M; Jenkins B; Waring P; Clay FJ; Malki S; Alderman BM; Grail D; Hollande F; Heath JK; Ernst M. 2002. Reciprocal regulation of gastrointestinal homeostasis by SHP2 and STAT-mediated trefoil gene activation in gp130 mutant mice. Nat Med 8(10):1089-97. [PubMed: 12219085]  [MGI Ref ID J:79073]

Thiem S; Pierce TP; Palmieri M; Putoczki TL; Buchert M; Preaudet A; Farid RO; Love C; Catimel B; Lei Z; Rozen S; Gopalakrishnan V; Schaper F; Hallek M; Boussioutas A; Tan P; Jarnicki A; Ernst M. 2013. mTORC1 inhibition restricts inflammation-associated gastrointestinal tumorigenesis in mice. J Clin Invest :. [PubMed: 23321674]  [MGI Ref ID J:194490]

Tieu BC; Lee C; Sun H; Lejeune W; Recinos A rd; Ju X; Spratt H; Guo DC; Milewicz D; Tilton RG; Brasier AR. 2009. An adventitial IL-6/MCP1 amplification loop accelerates macrophage-mediated vascular inflammation leading to aortic dissection in mice. J Clin Invest 119(12):3637-51. [PubMed: 19920349]  [MGI Ref ID J:155563]

Tissieres P; Dunn-Siegrist I; Schappi M; Elson G; Comte R; Nobre V; Pugin J. 2008. Soluble MD-2 is an acute-phase protein and an opsonin for Gram-negative bacteria. Blood 111(4):2122-31. [PubMed: 18056837]  [MGI Ref ID J:131315]

Tohyama J; Vanier MT; Suzuki K; Ezoe T; Matsuda J. 2000. Paradoxical influence of acid beta-galactosidase gene dosage on phenotype of the twitcher mouse (genetic galactosylceramidase deficiency) Hum Mol Genet 9(11):1699-707. [PubMed: 10861297]  [MGI Ref ID J:63197]

Tsantikos E; Oracki SA; Quilici C; Anderson GP; Tarlinton DM; Hibbs ML. 2010. Autoimmune disease in Lyn-deficient mice is dependent on an inflammatory environment established by IL-6. J Immunol 184(3):1348-60. [PubMed: 20042579]  [MGI Ref ID J:159526]

Turnbull AV; Prehar S; Kennedy AR; Little RA; Hopkins SJ. 2003. Interleukin-6 is an afferent signal to the hypothalamo-pituitary-adrenal axis during local inflammation in mice. Endocrinology 144(5):1894-906. [PubMed: 12697697]  [MGI Ref ID J:115710]

Tzelepis F; Joseph J; Haddad EK; Maclean S; Dudani R; Agenes F; Peng SL; Sekaly RP; Sad S. 2013. Intrinsic role of FoxO3a in the development of CD8+ T cell memory. J Immunol 190(3):1066-75. [PubMed: 23277488]  [MGI Ref ID J:193028]

Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M. 2006. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4. Int Immunol 18(9):1397-404. [PubMed: 16914507]  [MGI Ref ID J:113387]

Uematsu S; Fujimoto K; Jang MH; Yang BG; Jung YJ; Nishiyama M; Sato S; Tsujimura T; Yamamoto M; Yokota Y; Kiyono H; Miyasaka M; Ishii KJ; Akira S. 2008. Regulation of humoral and cellular gut immunity by lamina propria dendritic cells expressing Toll-like receptor 5. Nat Immunol 9(7):769-76. [PubMed: 18516037]  [MGI Ref ID J:137710]

Vallieres L; Rivest S. 1999. Interleukin-6 is a needed proinflammatory cytokine in the prolonged neural activity and transcriptional activation of corticotropin-releasing factor during endotoxemia. Endocrinology 140(9):3890-903. [PubMed: 10465257]  [MGI Ref ID J:110676]

Van Lenten BJ; Wagner AC; Navab M; Fogelman AM. 2001. Oxidized phospholipids induce changes in hepatic paraoxonase and ApoJ but not monocyte chemoattractant protein-1 via interleukin-6. J Biol Chem 276(3):1923-9. [PubMed: 11034996]  [MGI Ref ID J:67047]

Venihaki M; Dikkes P; Carrigan A; Karalis KP. 2001. Corticotropin-releasing hormone regulates IL-6 expression during inflammation. J Clin Invest 108(8):1159-66. [PubMed: 11602623]  [MGI Ref ID J:72196]

Vivien L; Benoist C; Mathis D. 2001. T lymphocytes need IL-7 but not IL-4 or IL-6 to survive in vivo. Int Immunol 13(6):763-8. [PubMed: 11369703]  [MGI Ref ID J:69776]

Vokaer B; Van Rompaey N; Lemaitre PH; Lhomme F; Kubjak C; Benghiat FS; Iwakura Y; Petein M; Field KA; Goldman M; Le Moine A; Charbonnier LM. 2010. Critical role of regulatory T cells in th17-mediated minor antigen-disparate rejection. J Immunol 185(6):3417-25. [PubMed: 20733201]  [MGI Ref ID J:163532]

Vonarbourg C; Mortha A; Bui VL; Hernandez PP; Kiss EA; Hoyler T; Flach M; Bengsch B; Thimme R; Holscher C; Honig M; Pannicke U; Schwarz K; Ware CF; Finke D; Diefenbach A. 2010. Regulated expression of nuclear receptor RORgammat confers distinct functional fates to NK cell receptor-expressing RORgammat(+) innate lymphocytes. Immunity 33(5):736-51. [PubMed: 21093318]  [MGI Ref ID J:167005]

Waldner MJ; Wirtz S; Jefremow A; Warntjen M; Neufert C; Atreya R; Becker C; Weigmann B; Vieth M; Rose-John S; Neurath MF. 2010. VEGF receptor signaling links inflammation and tumorigenesis in colitis-associated cancer. J Exp Med 207(13):2855-68. [PubMed: 21098094]  [MGI Ref ID J:176868]

Walker F; Zhang HH; Matthews V; Weinstock J; Nice EC; Ernst M; Rose-John S; Burgess AW. 2008. IL6/sIL6R complex contributes to emergency granulopoietic responses in G-CSF- and GM-CSF-deficient mice. Blood 111(8):3978-85. [PubMed: 18156493]  [MGI Ref ID J:134366]

Wallenius V; Wallenius K; Ahren B; Rudling M; Carlsten H; Dickson SL; Ohlsson C; Jansson JO. 2002. Interleukin-6-deficient mice develop mature-onset obesity. Nat Med 8(1):75-9. [PubMed: 11786910]  [MGI Ref ID J:73753]

Wallenius V; Wallenius K; Hisaoka M; Sandstedt J; Ohlsson C; Kopf M; Jansson JO. 2001. Retarded liver growth in interleukin-6-deficient and tumor necrosis factor receptor-1-deficient mice. Endocrinology 142(7):2953-60. [PubMed: 11416016]  [MGI Ref ID J:71930]

Wan Z; Perry CG; Macdonald T; Chan CB; Holloway GP; Wright DC. 2012. IL-6 is not necessary for the regulation of adipose tissue mitochondrial content. PLoS One 7(12):e51233. [PubMed: 23240005]  [MGI Ref ID J:195675]

Wan Z; Ritchie I; Beaudoin MS; Castellani L; Chan CB; Wright DC. 2012. IL-6 indirectly modulates the induction of glyceroneogenic enzymes in adipose tissue during exercise. PLoS One 7(7):e41719. [PubMed: 22844518]  [MGI Ref ID J:189714]

Wang H; Guan Q; Lan Z; Li S; Ge W; Chen H; Nguan CY; Du C. 2012. Prolonged renal allograft survival by donor interleukin-6 deficiency: association with decreased alloantibodies and increased intragraft T regulatory cells. Am J Physiol Renal Physiol 302(2):F276-83. [PubMed: 22031852]  [MGI Ref ID J:180244]

Wang J; Homer RJ; Chen Q; Elias JA. 2000. Endogenous and exogenous IL-6 inhibit aeroallergen-induced Th2 inflammation. J Immunol 165(7):4051-61. [PubMed: 11034416]  [MGI Ref ID J:118443]

Wang Q; Fang CH; Hasselgren PO. 2001. Intestinal permeability is reduced and IL-10 levels are increased in septic IL-6 knockout mice. Am J Physiol Regul Integr Comp Physiol 281(3):R1013-23. [PubMed: 11507020]  [MGI Ref ID J:71507]

Wang T; Town T; Alexopoulou L; Anderson JF; Fikrig E; Flavell RA. 2004. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat Med 10(12):1366-73. [PubMed: 15558055]  [MGI Ref ID J:99595]

Wang XP; Schunck M; Kallen KJ; Neumann C; Trautwein C; Rose-John S; Proksch E. 2004. The interleukin-6 cytokine system regulates epidermal permeability barrier homeostasis. J Invest Dermatol 123(1):124-31. [PubMed: 15191552]  [MGI Ref ID J:90509]

Wang Y; Ait-Oufella H; Herbin O; Bonnin P; Ramkhelawon B; Taleb S; Huang J; Offenstadt G; Combadiere C; Renia L; Johnson JL; Tharaux PL; Tedgui A; Mallat Z. 2010. TGF-beta activity protects against inflammatory aortic aneurysm progression and complications in angiotensin II-infused mice. J Clin Invest 120(2):422-32. [PubMed: 20101093]  [MGI Ref ID J:156667]

Warren GL; Hulderman T; Jensen N; McKinstry M; Mishra M; Luster MI; Simeonova PP. 2002. Physiological role of tumor necrosis factor alpha in traumatic muscle injury. FASEB J 16(12):1630-2. [PubMed: 12207010]  [MGI Ref ID J:119897]

Weigmann B; Lehr HA; Yancopoulos G; Valenzuela D; Murphy A; Stevens S; Schmidt J; Galle PR; Rose-John S; Neurath MF. 2008. The transcription factor NFATc2 controls IL-6-dependent T cell activation in experimental colitis. J Exp Med 205(9):2099-110. [PubMed: 18710929]  [MGI Ref ID J:138976]

Weinmann P; Scharffetter-Kochanek K; Forlow SB; Peters T; Walzog B. 2003. A role for apoptosis in the control of neutrophil homeostasis in the circulation: insights from CD18-deficient mice. Blood 101(2):739-46. [PubMed: 12393639]  [MGI Ref ID J:115556]

Weissenberger J; Loeffler S; Kappeler A; Kopf M; Lukes A; Afanasieva TA; Aguzzi A; Weis J. 2004. IL-6 is required for glioma development in a mouse model. Oncogene 23(19):3308-16. [PubMed: 15064729]  [MGI Ref ID J:89585]

Wernstedt I; Olsson B; Jernas M; Paglialunga S; Carlsson LM; Smith U; Cianflone K; Wallenius K; Wallenius V. 2006. Increased levels of acylation-stimulating protein in interleukin-6-deficient (IL-6(-/-)) mice. Endocrinology 147(6):2690-5. [PubMed: 16513824]  [MGI Ref ID J:129659]

West DM; Del Rosso CR; Yin XT; Stuart PM. 2014. CXCL1 but not IL-6 is required for recurrent herpetic stromal keratitis. J Immunol 192(4):1762-7. [PubMed: 24442436]  [MGI Ref ID J:209364]

Westberg JA; Serlachius M; Lankila P; Andersson LC. 2007. Hypoxic preconditioning induces elevated expression of stanniocalcin-1 in the heart. Am J Physiol Heart Circ Physiol 293(3):H1766-71. [PubMed: 17573464]  [MGI Ref ID J:126148]

Wojewoda M; Kmiecik K; Ventura-Clapier R; Fortin D; Onopiuk M; Jakubczyk J; Sitek B; Fedorowicz A; Majerczak J; Kaminski K; Chlopicki S; Zoladz JA. 2014. Running performance at high running velocities is impaired but V'O((2)max) and peripheral endothelial function are preserved in IL-6(-)/(-) mice. PLoS One 9(2):e88333. [PubMed: 24533077]  [MGI Ref ID J:212940]

Wong PK; Egan PJ; Croker BA; O'Donnell K; Sims NA; Drake S; Kiu H; McManus EJ; Alexander WS; Roberts AW; Wicks IP. 2006. SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritis. J Clin Invest 116(6):1571-81. [PubMed: 16710471]  [MGI Ref ID J:110372]

Wu HJ; Sawaya H; Binstadt B; Brickelmaier M; Blasius A; Gorelik L; Mahmood U; Weissleder R; Carulli J; Benoist C; Mathis D. 2007. Inflammatory arthritis can be reined in by CpG-induced DC-NK cell cross talk. J Exp Med 204(8):1911-22. [PubMed: 17646407]  [MGI Ref ID J:125952]

Wu Y; El Shikh ME; El Sayed RM; Best AM; Szakal AK; Tew JG. 2009. IL-6 produced by immune complex-activated follicular dendritic cells promotes germinal center reactions, IgG responses and somatic hypermutation. Int Immunol 21(6):745-56. [PubMed: 19461124]  [MGI Ref ID J:149530]

Wuestefeld T; Klein C; Streetz KL; Betz U; Lauber J; Buer J; Manns MP; Muller W; Trautwein C. 2003. Interleukin-6/glycoprotein 130-dependent pathways are protective during liver regeneration. J Biol Chem 278(13):11281-8. [PubMed: 12509437]  [MGI Ref ID J:91064]

Xia M; Liu J; Wu X; Liu S; Li G; Han C; Song L; Li Z; Wang Q; Wang J; Xu T; Cao X. 2013. Histone methyltransferase Ash1l suppresses interleukin-6 production and inflammatory autoimmune diseases by inducing the ubiquitin-editing enzyme A20. Immunity 39(3):470-81. [PubMed: 24012418]  [MGI Ref ID J:208213]

Xing Z; Gauldie J; Cox G; Baumann H; Jordana M; Lei XF; Achong MK. 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J Clin Invest 101(2):311-20. [PubMed: 9435302]  [MGI Ref ID J:118763]

Yang CY; Leung PS; Yang GX; Kenny TP; Zhang W; Coppel R; Norman GL; Ansari AA; Mackay IR; Worman HJ; Gershwin ME. 2012. Epitope-specific anti-nuclear antibodies are expressed in a mouse model of primary biliary cirrhosis and are cytokine-dependent. Clin Exp Immunol 168(3):261-7. [PubMed: 22519587]  [MGI Ref ID J:184866]

Yang J; Chen J; Yan J; Zhang L; Chen G; He L; Wang Y. 2012. Effect of interleukin 6 deficiency on renal interstitial fibrosis. PLoS One 7(12):e52415. [PubMed: 23272241]  [MGI Ref ID J:195642]

Yang R; Han X; Uchiyama T; Watkins SK; Yaguchi A; Delude RL; Fink MP. 2003. IL-6 is essential for development of gut barrier dysfunction after hemorrhagic shock and resuscitation in mice. Am J Physiol Gastrointest Liver Physiol 285(3):G621-9. [PubMed: 12773301]  [MGI Ref ID J:85434]

Yang S; Ryu JH; Oh H; Jeon J; Kwak JS; Kim JH; Kim HA; Chun CH; Chun JS. 2013. NAMPT (visfatin), a direct target of hypoxia-inducible factor-2alpha, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis :. [PubMed: 24347567]  [MGI Ref ID J:206286]

Yang X; Ricciardi BF; Hernandez-Soria A; Shi Y; Pleshko Camacho N; Bostrom MP. 2007. Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone 41(6):928-36. [PubMed: 17921078]  [MGI Ref ID J:141482]

Yi AK; Yoon H; Park JE; Kim BS; Kim HJ; Martinez-Hernandez A. 2006. CpG DNA-mediated induction of acute liver injury in D-galactosamine-sensitized mice: the mitochondrial apoptotic pathway-dependent death of hepatocytes. J Biol Chem 281(21):15001-12. [PubMed: 16554296]  [MGI Ref ID J:113473]

Yimin; Kohanawa M; Minagawa T. 2003. Up-regulation of granulomatous inflammation in interleukin-6 knockout mice infected with Rhodococcus aurantiacus. Immunology 110(4):501-6. [PubMed: 14632648]  [MGI Ref ID J:113603]

Yoh K; Morito N; Ojima M; Shibuya K; Yamashita Y; Morishima Y; Ishii Y; Kusakabe M; Nishikii H; Fujita A; Matsunaga E; Okamura M; Hamada M; Suto A; Nakajima H; Shibuya A; Yamagata K; Takahashi S. 2012. Overexpression of RORgammat under control of the CD2 promoter induces polyclonal plasmacytosis and autoantibody production in transgenic mice. Eur J Immunol 42(8):1999-2009. [PubMed: 22623033]  [MGI Ref ID J:187853]

Yu M; Zheng X; Witschi H; Pinkerton KE. 2002. The role of interleukin-6 in pulmonary inflammation and injury induced by exposure to environmental air pollutants. Toxicol Sci 68(2):488-97. [PubMed: 12151646]  [MGI Ref ID J:126238]

Zenewicz LA; Yancopoulos GD; Valenzuela DM; Murphy AJ; Karow M; Flavell RA. 2007. Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27(4):647-59. [PubMed: 17919941]  [MGI Ref ID J:126103]

Zhang H; Ching S; Chen Q; Li Q; An Y; Quan N. 2008. Localized inflammation in peripheral tissue signals the CNS for sickness response in the absence of interleukin-1 and cyclooxygenase-2 in the blood and brain. Neuroscience 157(4):895-907. [PubMed: 18950689]  [MGI Ref ID J:144882]

Zhang H; Wang HY; Bassel-Duby R; Maass DL; Johnston WE; Horton JW; Tao W. 2007. Role of interleukin-6 in cardiac inflammation and dysfunction after burn complicated by sepsis. Am J Physiol Heart Circ Physiol 292(5):H2408-16. [PubMed: 17220181]  [MGI Ref ID J:125958]

Zhang J; Alcaide P; Liu L; Sun J; He A; Luscinskas FW; Shi GP. 2011. Regulation of endothelial cell adhesion molecule expression by mast cells, macrophages, and neutrophils. PLoS One 6(1):e14525. [PubMed: 21264293]  [MGI Ref ID J:169463]

Zhang J; Zhu Y; Zhan G; Fenik P; Panossian L; Wang MM; Reid S; Lai D; Davis JG; Baur JA; Veasey S. 2014. Extended wakefulness: compromised metabolics in and degeneration of locus ceruleus neurons. J Neurosci 34(12):4418-31. [PubMed: 24647961]  [MGI Ref ID J:210306]

Zhang W; Tsuda M; Yang GX; Tsuneyama K; He XS; Ansari AA; Ridgway WM; Coppel RL; Lian ZX; Leung PS; Gershwin ME. 2012. Lymphoma-like T cell infiltration in liver is associated with increased copy number of dominant negative form of TGFbeta receptor II. PLoS One 7(11):e49413. [PubMed: 23145171]  [MGI Ref ID J:194795]

Zhang X; Goel T; Goodfield LL; Muse SJ; Harvill ET. 2011. Decreased leukocyte accumulation and delayed Bordetella pertussis clearance in IL-6-/- mice. J Immunol 186(8):4895-904. [PubMed: 21398615]  [MGI Ref ID J:172453]

Zhang X; Munegowda MA; Yuan J; Wei Y; Xiang J. 2010. Optimal TLR9 signal converts tolerogenic CD4-8- DCs into immunogenic ones capable of stimulating antitumor immunity via activating CD4+ Th1/Th17 and NK cell responses. J Leukoc Biol 88(2):393-403. [PubMed: 20466823]  [MGI Ref ID J:163943]

Zhang Y; Yan W; Collins MA; Bednar F; Rakshit S; Zetter BR; Stanger BZ; Chung I; Rhim AD; di Magliano MP. 2013. Interleukin-6 is required for pancreatic cancer progression by promoting MAPK signaling activation and oxidative stress resistance. Cancer Res 73(20):6359-74. [PubMed: 24097820]  [MGI Ref ID J:205411]

Zhao L; Melenhorst JJ; Hennighausen L. 2002. Loss of interleukin 6 results in delayed mammary gland involution: a possible role for mitogen-activated protein kinase and not signal transducer and activator of transcription 3. Mol Endocrinol 16(12):2902-12. [PubMed: 12456808]  [MGI Ref ID J:125449]

Zheng Y; Danilenko DM; Valdez P; Kasman I; Eastham-Anderson J; Wu J; Ouyang W. 2007. Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445(7128):648-51. [PubMed: 17187052]  [MGI Ref ID J:118261]

Zheng Y; Valdez PA; Danilenko DM; Hu Y; Sa SM; Gong Q; Abbas AR; Modrusan Z; Ghilardi N; de Sauvage FJ; Ouyang W. 2008. Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14(3):282-9. [PubMed: 18264109]  [MGI Ref ID J:161073]

Zhong J; Dietzel ID; Wahle P; Kopf M; Heumann R. 1999. Sensory impairments and delayed regeneration of sensory axons in interleukin-6-deficient mice. J Neurosci 19(11):4305-13. [PubMed: 10341234]  [MGI Ref ID J:55028]

Zhong Y; Cantwell A; Dube PH. 2010. Transforming growth factor beta and CD25 are important for controlling systemic dissemination following Yersinia enterocolitica infection of the gut. Infect Immun 78(9):3716-25. [PubMed: 20584975]  [MGI Ref ID J:163014]

Zhou J; Tang PC; Qin L; Gayed PM; Li W; Skokos EA; Kyriakides TR; Pober JS; Tellides G. 2010. CXCR3-dependent accumulation and activation of perivascular macrophages is necessary for homeostatic arterial remodeling to hemodynamic stresses. J Exp Med 207(9):1951-66. [PubMed: 20733031]  [MGI Ref ID J:165720]

Zhou L; Ivanov II; Spolski R; Min R; Shenderov K; Egawa T; Levy DE; Leonard WJ; Littman DR. 2007. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 8(9):967-74. [PubMed: 17581537]  [MGI Ref ID J:124293]

de Hooge AS; van De Loo FA; Arntz OJ; van Den Berg WB. 2000. Involvement of IL-6, apart from its role in immunity, in mediating a chronic response during experimental arthritis Am J Pathol 157(6):2081-91. [PubMed: 11106580]  [MGI Ref ID J:66135]

de Hooge AS; van de Loo FA; Koenders MI; Bennink MB; Arntz OJ; Kolbe T; van den Berg WB. 2004. Local activation of STAT-1 and STAT-3 in the inflamed synovium during zymosan-induced arthritis: exacerbation of joint inflammation in STAT-1 gene-knockout mice. Arthritis Rheum 50(6):2014-23. [PubMed: 15188379]  [MGI Ref ID J:106196]

van der Poll T; Keogh CV; Guirao X; Buurman WA; Kopf M; Lowry SF. 1997. Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia. J Infect Dis 176(2):439-44. [PubMed: 9237710]  [MGI Ref ID J:41791]

von Felbert V; Cordoba F; Weissenberger J; Vallan C; Kato M; Nakashima I; Braathen LR; Weis J. 2005. Interleukin-6 gene ablation in a transgenic mouse model of malignant skin melanoma. Am J Pathol 166(3):831-41. [PubMed: 15743795]  [MGI Ref ID J:96719]

Health & husbandry

Health & Colony Maintenance Information

Animal Health Reports

Room Number           AX11

Colony Maintenance

Breeding & HusbandryThis strain is maintained by mating homozygous siblings. Expected coat color from breeding:Black
Mating SystemHomozygote x Homozygote         (Female x Male)   01-MAR-06
Diet Information LabDiet® 5K52/5K67

Pricing and Purchasing

Pricing, Supply Level & Notes, Controls

Pricing for USA, Canada and Mexico shipping destinations View International Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $320.00Female or MaleHomozygous for Il6tm1Kopf  
Price per Pair (US dollars $)Pair Genotype
$640.00Homozygous for Il6tm1Kopf x Homozygous for Il6tm1Kopf  

Standard Supply

Repository-Live represents an exclusive set of over 1800 unique mouse models across a vast array of research areas. Breeding colonies provide mice for large and small orders and fluctuate in size depending on current research demand. If a strain is not immediately available, you will receive an estimated availability timeframe for your inquiry or order in 2-3 business days. Repository strains typically are delivered at 4 to 8 weeks of age. Requests for specific ages will be noted but not guaranteed and we do not accept age requests for breeder pairs. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, we will do our best to accommodate your age request.

Pricing for International shipping destinations View USA Canada and Mexico Pricing

Live Mice

Price per mouse (US dollars $)GenderGenotypes Provided
Individual Mouse $416.00Female or MaleHomozygous for Il6tm1Kopf  
Price per Pair (US dollars $)Pair Genotype
$832.00Homozygous for Il6tm1Kopf x Homozygous for Il6tm1Kopf  

Standard Supply

Repository-Live represents an exclusive set of over 1800 unique mouse models across a vast array of research areas. Breeding colonies provide mice for large and small orders and fluctuate in size depending on current research demand. If a strain is not immediately available, you will receive an estimated availability timeframe for your inquiry or order in 2-3 business days. Repository strains typically are delivered at 4 to 8 weeks of age. Requests for specific ages will be noted but not guaranteed and we do not accept age requests for breeder pairs. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, we will do our best to accommodate your age request.

View USA Canada and Mexico Pricing View International Pricing

Standard Supply

Repository-Live represents an exclusive set of over 1800 unique mouse models across a vast array of research areas. Breeding colonies provide mice for large and small orders and fluctuate in size depending on current research demand. If a strain is not immediately available, you will receive an estimated availability timeframe for your inquiry or order in 2-3 business days. Repository strains typically are delivered at 4 to 8 weeks of age. Requests for specific ages will be noted but not guaranteed and we do not accept age requests for breeder pairs. However, if cohorts of mice (5 or more of one gender) are needed at a specific age range for experiments, we will do our best to accommodate your age request.

Control Information

   101045 B6129SF2/J (approximate)
  Considerations for Choosing Controls
  Control Pricing Information for Genetically Engineered Mutant Strains.

Payment Terms and Conditions

Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.

See Terms of Use tab for General Terms and Conditions

The Jackson Laboratory's Genotype Promise

The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project.
Ordering Information
JAX® Mice
Surgical and Preconditioning Services
JAX® Services
Customer Services and Support
Tel: 1-800-422-6423 or 1-207-288-5845
Fax: 1-207-288-6150
Technical Support Email Form

Terms of Use

Terms of Use

General Terms and Conditions

For Licensing and Use Restrictions view the link(s) below:
- Notice regarding distribution of this strain.

Contact information

General inquiries regarding Terms of Use

Contracts Administration


JAX® Mice, Products & Services Conditions of Use

"MICE" means mouse strains, their progeny derived by inbreeding or crossbreeding, unmodified derivatives from mouse strains or their progeny supplied by The Jackson Laboratory ("JACKSON"). "PRODUCTS" means biological materials supplied by JACKSON, and their derivatives. "RECIPIENT" means each recipient of MICE, PRODUCTS, or services provided by JACKSON including each institution, its employees and other researchers under its control. MICE or PRODUCTS shall not be: (i) used for any purpose other than the internal research, (ii) sold or otherwise provided to any third party for any use, or (iii) provided to any agent or other third party to provide breeding or other services. Acceptance of MICE or PRODUCTS from JACKSON shall be deemed as agreement by RECIPIENT to these conditions, and departure from these conditions requires JACKSON's prior written authorization.

No Warranty


In case of dissatisfaction for a valid reason and claimed in writing by a purchaser within ninety (90) days of receipt of mice, products or services, JACKSON will, at its option, provide credit or replacement for the mice or product received or the services provided.

No Liability

In no event shall JACKSON, its trustees, directors, officers, employees, and affiliates be liable for any causes of action or damages, including any direct, indirect, special, or consequential damages, arising out of the provision of MICE, PRODUCTS or services, including economic damage or injury to property and lost profits, and including any damage arising from acts or negligence on the part of JACKSON, its agents or employees. Unless prohibited by law, in purchasing or receiving MICE, PRODUCTS or services from JACKSON, purchaser or recipient, or any party claiming by or through them, expressly releases and discharges JACKSON from all such causes of action or damages, and further agrees to defend and indemnify JACKSON from any costs or damages arising out of any third party claims.

MICE and PRODUCTS are to be used in a safe manner and in accordance with all applicable governmental rules and regulations.

The foregoing represents the General Terms and Conditions applicable to JACKSON’s MICE, PRODUCTS or services. In addition, special terms and conditions of sale of certain MICE, PRODUCTS or services may be set forth separately in JACKSON web pages, catalogs, price lists, contracts, and/or other documents, and these special terms and conditions shall also govern the sale of these MICE, PRODUCTS and services by JACKSON, and by its licensees and distributors.

Acceptance of delivery of MICE, PRODUCTS or services shall be deemed agreement to these terms and conditions. No purchase order or other document transmitted by purchaser or recipient that may modify the terms and conditions hereof, shall be in any way binding on JACKSON, and instead the terms and conditions set forth herein, including any special terms and conditions set forth separately, shall govern the sale of MICE, PRODUCTS or services by JACKSON.